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5 Summary 
The visual impairment and intracranial pressure (VIIP) syndrome affects more than 
half of astronauts during 6-month missions on the International Space Station (ISS) resulting 
in significant structural and functional ophthalmic changes. Although the exact 
pathophysiological mechanisms underlying the ocular changes are unknown, headward fluid 
shifting due to the absence of gravity and subsequent alterations in cerebral hemodynamics 
and intracranial pressure (ICP) may play a major role. The overarching aim of this thesis was 
to elucidate the effects of cephalad fluid shifting during head-down tilt (HDT), commonly 
used as a spaceflight analog model, on cerebral and ocular anatomy and physiology. As a 
secondary aim, the potential additive effects of increased ambient carbon dioxide (CO2) 
during HDT were assessed as well as the ability of lower body negative pressure (LBNP) to 
counteract headward fluid shifting. 
The scope of the PhD thesis work was split into three main studies. In the first study, 
cerebral as well as ocular fluid and pressure balance was assessed during 5 h HDT exposure 
in 5 experimental conditions: -6°, -12° and -18° HDT, -12° with 1% CO2 and -12° HDT with -20 
mmHg LBNP. Thereafter, the second study investigated a longer duration exposure to -12° 
HDT (29 h) with and without increased ambient CO2. Finally, the third study tested the 
effects of stronger LBNP (-40 mmHg) for shorter durations of time with an extended range 
of tilt angles.  
The results show that HDT leads to signs of cerebral venous congestion 
demonstrated by the large increase in internal jugular vein cross-sectional area and 
decreased cerebral venous outflow. Furthermore, HDT induced increases in intracranial as 
well as periorbital cerebrospinal fluid (CSF) volume, consistent with decreased CSF 
absorption due to elevated cerebral venous pressure. Intraocular pressure (IOP) remained 
greater than ICP during HDT, resulting in a small, positive intraocular-intracranial pressure 
difference (IOP > ICP) during both acute and overnight HDT, contrary to the hypothesized 
shift to a greater ICP. In addition, exposure to increased ambient CO2 on the ISS was 
hypothesized to be a contributing factor to the ocular changes in astronauts by further 
increasing intracranial blood volume and therefore pressure. In combination with HDT, 
exposure to elevated ambient CO2 increased cerebral blood flow and venous outflow, 
however, had little additive effect on IOP or ICP during acute or longer-duration exposure. 
2 
 
Alterations in cerebral hemodynamics secondary to headward fluid shifting are central to 
the hypothesized mechanisms underlying the VIIP syndrome and may induce a cascade of 
ophthalmic changes over long-duration exposure. 
Finding a way to mitigate vision changes in space is vital to ensure long-duration 
exploration class mission feasibility and success. Therefore, LBNP, a technique that 
redistributes venous blood volume to the lower limbs, was tested as a mechanical 
countermeasure to cephalad fluid shifting. Notably, low-level LBNP (-20 mmHg) during -12° 
HDT was able to successfully attenuate the HDT-induced increase in periorbital as well as 
intracranial CSF volume. Although -20 mmHg LBNP had no effect on IOP or ICP, exposure to -
40 mmHg LBNP was able to attenuate HDT-induced increases in IOP during a range of tilt 
angles.  
Overall, the presented studies represent novel investigations into the cerebral and 
ocular effects of various degrees of cephalad fluid shifting as well as the unique combination 
of HDT and increased ambient CO2 as a more realistic analog of the ISS environment. 
Impediment of venous return by LBNP was also established as a promising technique to 
counteract cephalad fluid shifting and redistribute CSF and may be able prevent future 
development of structural ocular changes associated with the VIIP syndrome. These studies 
have contributed to the further understanding of potential mechanisms involved in the 
development of ocular changes in astronauts, notably the central role of cerebral 
hemodynamics and cerebral venous congestion. 
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6 Zusammenfassung 
Mehr als die Hälfte aller Astronauten sind nach 6-monatigen Missionen auf der 
Internationalen Raumstation (ISS) vom VIIP-Syndrom (von der engl. Bezeichnung Visual 
Impairment and Intracranial Pressure, Sehstörungen und Hirndruck) betroffen. Dieses führt 
zu erheblichen funktionellen und strukturellen Veränderungen des Auges. Die genauen 
pathophysiologischen Vorgänge, die zu diesen Veränderungen am Auge führen, sind 
unbekannt. Kopfwärts-gerichtete Verschiebungen von Flüssigkeit infolge der 
Schwerelosigkeit mit nachfolgenden Veränderungen der zerebralen Hämodynamik und des 
Hirndrucks (Intracranial Pressure, ICP) könnten jedoch ein wesentlicher Faktor sein. 
Hauptziel dieser Arbeit war die Klärung der Folgen der Flüssigkeitverschiebungen beim 
Head-Down-Tilt (HDT, Kopftieflage) auf die Anatomie und Physiologie von Gehirn und Auge. 
HDT wird üblicherweise als Simulationsmodell für die Raumfahrt herangezogen. Als weiteres 
Ziel wurden die potenziellen additiven Folgen eines erhöhten Kohlenstoffdioxidgehalts (CO2) 
in der Umgebung beim HDT sowie die Möglichkeit bewertet, durch den Einsatz von LBNP-
Systemen (von der engl. Bezeichnung Lower Body Negative Pressure, Unterdruck auf die 
untere Körperhälfte) der Kopfwärtsverlagerung von Flüssigkeit entgegenzuwirken. 
Im Rahmen dieser Dissertation wurden drei Hauptstudien durchgeführt. Bei der 
ersten Studie wurde der Flüssigkeits- und Druckausgleich an Gehirn und Auge in 5 HDT-
Versuchsanordnungen evaluiert: HDT (5 h) von −6°, −12° und −18°, HDT von −12° mit 1 % 
CO2 und −12° mit LBNP von −20 mmHg. Im Anschluss wurde bei der zweiten Studie eine 
längere Exposition bei einem HDT von −12° (29 h) mit und ohne erhöhten CO2-Gehalt in der 
Umgebung untersucht. Bei der dritten Studie wurden die Folgen eines höheren LBNP 
(−40 mmHg) über kürzere Zeiträume bei einem größeren Bereich von HDT-Winkeln getestet.  
Die Ergebnisse zeigen, dass ein HDT zu Anzeichen von venösen Stauungen im Gehirn 
führt, wie die starke Vergrößerung der Querschnittsfläche der v. jugularis interna und die 
Verringerung des zerebral-venösen Abflusses zeigen. Der HDT führte zudem zu einem 
erhöhten intrakraniellen und periorbitalen Volumen der liquor cerebrospinalis, was im 
Einklang mit einer verminderten Liquor-Resorption aufgrund des erhöhten zerebralen 
Venendrucks steht. Der Augeninnendruck (Intraocular Pressure, IOP) erhöhte sich beim HDT 
stärker als der ICP, sodass es sowohl bei akuter HDT-Exposition als auch bei Exposition über 
Nacht zu einer verringerten, aber immer noch positiven Differenz zwischen 
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Augeninnendruck und Hirndruck (IOP > ICP) kam. Dies widersprach der in den 
ursprünglichen Hypothesen erwarteten Entwicklung eines höheren ICP.  
Außerdem wird ein erhöhter CO2-Gehalt in der Umgebung in der ISS als Mit-
Verursacher für Augenveränderungen bei Astronauten angenommen, da das Blutvolumen 
und damit auch der Druck im Gehirn dadurch weiter steigen. Zusammen mit dem HDT 
führte die Exposition bei erhöhtem CO2-Gehalt in der Umgebung zu einer Steigerung des 
Blutflusses in den Zerebral-Arterien und -Venen. Die additiven Folgen für IOP und ICP bei 
akuter Exposition und bei einer Exposition über einen längeren Zeitraum waren jedoch 
gering. Veränderungen der zerebralen Hämodynamik durch die Kopfwärtsverlagerung von 
Flüssigkeit sind von zentraler Bedeutung für die angenommenen Vorgänge hinter dem VIIP-
Syndrom und können bei Langzeitexposition eine ganze Reihe von Augenveränderungen 
bedingen. 
Es müssen unbedingt Möglichkeiten zur Minderung der Veränderungen der Sehkraft 
in der Raumfahrt aufgetan werden, um Machbarkeit und Erfolg von 
Langzeitforschungsmissionen sicherzustellen. Daher wurde LBNP als Verfahren zur 
Umverteilung des venösen Blutvolumens in die unteren Extremitäten als mechanische 
Gegenmaßnahme zur Kopfwärtsverlagerung von Flüssigkeit getestet. Insbesondere mit 
einem niedrigen LBNP (−20 mmHg) bei einem HDT von −12° konnte die durch den HDT 
verursachte Erhöhung des periorbitalen und intrakraniellen Liquor-Volumens erfolgreich 
abgeschwächt werden. Während ein LBNP von −20 mmHg keinen Einfluss auf IOP und ICP 
hatte, konnten mit einem LBNP von −40 mmHg die durch HDT ausgelöste Erhöhung des IOP 
bei verschiedenen HDT-Winkeln abgeschwächt werden.  
Zusammengefasst präsentieren die vorgelegten Studien innovative Untersuchungen 
zu den Folgen verschiedener Ausmaße der Kopfwärts-gerichteten Verschiebung von 
Flüssigkeit auf Gehirn und Auge sowie zu der besonderen Kombination aus HDT und 
erhöhtem CO2-Gehalt in der Umgebung als realistischere Simulation der ISS-Umgebung. 
Zudem wurde festgestellt, dass Reduktion des venösen Rückstroms, z.B. durch LNBP, in der 
Lage zu sein scheint, die kopfwärts-gerichteten Liquorverschiebungen zu unterbinden, 
sodass strukturellen Augenveränderungen durch das VIIP-Syndrom zukünftig 
möglicherweise vorgebeugt werden kann. Die Studien haben das Verständnis der möglichen 
Vorgänge bei der Herausbildung von Augenveränderungen erweitert und damit zur 
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Untersuchung der zentralen Rolle der zerebralen Hämodynamik und venöser Stauungen im 
Gehirn beigetragen. 
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7 Introduction 
 
7.1  Ophthalmic Abnormalities in Astronauts 
Exposure to microgravity affects the homeostatic physiology of many human body 
systems as humans are adapted to a 1-G environment. The effects of short and long-
duration exposure to microgravity have been well studied over the past 50 years of human 
spaceflight including cardiovascular, vestibular and musculoskeletal adaptations (14, 57). 
For decades, there have also been anecdotal reports of visual impairment during 
spaceflight, much of which was attributed to the age of the flying population. However, with 
the deployment of the International Space Station (ISS), continuously inhabited by 4-6 
residents since 2000, insights into the effects of long-duration microgravity exposure on the 
cerebral and ocular systems has greatly increased. With the recent advancement of on-
board medical imaging capabilities, it has been determined that the anecdotal changes in 
vision are accompanied by a number of structural changes. This Visual Impairment and 
Intracranial Pressure (VIIP) syndrome (3), also known as the Microgravity Ocular Syndrome 
(MOS; 56), is associated with varying degrees of optic disc edema, globe flattening, 
choroidal folds, cotton wool spots, optic nerve (ON) sheath distension, increased 
intracranial pressure (ICP) post-flight and hyperopic refractive error shifts (69, 78, 82, 92). 
Since year 2000, the VIIP syndrome has affected more than 65% of American 
astronauts to varying degrees with unknown long-term implications. A 4-tier classification 
system has been developed to rank the severity of the affected astronauts, with the 
majority of astronauts (59%) presenting with class 2 of the VIIP syndrome (Table 1). 
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Table 1: VIIP syndrome classification for astronauts and the percentage of VIIP-affected astronauts in 
each classification 
 
 Affected 
Astronauts Class definition 
Class 1 9% • ≥ .50 diopter cycloplegic refractive change 
• And/or cotton wool spot 
Class 2 59% Class 1 findings and: 
• Choroidal folds 
• And/or optic nerve sheath distension 
• And/or globe flattening 
• And/or scotoma 
Class 3 14% Class 2 findings and: 
• Papilledema of Grade 0-2 on the Frisen scale (39) 
Class 4 18% Class 2 findings and: 
• Papilledema grade > 2 on the Frisen scale 
• Symptoms of new heachache, pulsatile tinnitus and/or transient 
visual obscurations 
• CSF opening pressure > 18.4 mmHg (24 cm H2O) 
 
CSF = cerebrospinal fluid (Source: NASA, 2012) 
 
While the exact etiology of the ocular changes in astronauts is currently unknown, 
increased ICP has been widely hypothesized to be a contributing factor due to similar signs 
and symptoms seen in patients on Earth with idiopathic intracranial hypertension (IIH, also 
known as pseudotumor cerebri), that is, increased ICP with an unknown cause. Thus, 
research efforts have been turned to understanding the cerebral and ocular effects of real 
and simulated microgravity to better understand underlying mechanisms in the VIIP 
syndrome and ultimately, to mitigate these risks through countermeasures.  
 
7.2 Intracranial and Ocular Anatomy and Physiology: General Introduction 
7.2.1 The Intracranial Compartment 
As the cranium is non-distensible, the intracranial space has a fixed volume made up 
of ~100-130 ml blood (15% arterial, 40% venous, 45% microcirculation), ~75 ml of 
cerebrospinal fluid (CSF) and brain tissue (93). According to the classical Monro-Kelli 
doctrine (88), the sum of the volume of these three intracranial components is constant, 
therefore, any increase in one will lead to a compensatory decrease in another (mainly CSF 
or blood volume). This can be seen for both slow (i.e., a mass lesion) and fast processes (i.e., 
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arterial pulsatility). However, when the compensatory reserve is low (a shift to the right of 
the intracranial pressure-volume curve), any increase in intracranial volume will lead to a 
large rise in ICP (Figure 1; 11, 27). Decreased cranial compliance and increased ICP and flow 
pulsatility are seen in many pathologies including traumatic brain injury and hydrocephalus 
(124). Interestingly, changes in cranial compliance occur daily in healthy individuals as well, 
primarily with changes in posture (5), however, within the clinical norm.  
 
Figure 1: The theoretical intracranial pressure-volume curve demonstrates that when compensatory 
reserve is present, a certain change in intracranial volume (ΔV1) results in a small increase in 
intracranial pressure (ΔP1). However, once compensatory reserve is exhausted, the same increase in 
volume (ΔV1) will result in a much larger increase in pressure (ΔP2). 
 
ICP is subject to large variations with posture as both the CSF and vascular systems 
are subject to hydrostatic pressure gradients on Earth. In the upright position, ICP is 
normally 0 mmHg (or negative) at the level of the external auditory meatus (96, 99), 
whereas in the supine position, ICP averages about 10 mmHg in healthy adults (34). The 
classical hypothesis of CSF hydrodynamics is that CSF is produced primarily in the choroid 
plexuses and ependymal surfaces of the brain ventricles (95) and flows in a unidirectional 
manner from the brain ventricles into the subarachnoid space (SAS), which lies between the 
innermost layers of the meninges surrounding the central nervous system (pia matter and 
arachnoid matter). Recently, CSF circulation has been found to be much more complex than 
initially thought, involving directed bulk flow, pulsatile movement, and continuous fluid 
exchange between CSF and the blood brain barrier (23). The CSF-filled SAS continues around 
the brain, spinal cord and along several nerve tracks, most notably the ON (Figure 2). The 
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bulk of CSF is then absorbed through the arachnoid villi of the dural venous sinuses into the 
cerebral venous system, although there is increasing evidence that the lymphatic system 
plays a role in CSF resorption as well (87, 95). Absorption of CSF into the venous sinuses in 
the arachnoid villi is dependent upon a pressure gradient (PCSF – PVenous). According to the 
Davson equation (Equation 1-1; 28),  
 
 
𝐼𝐼𝐼𝐼𝐼𝐼 = 𝑅𝑅𝑜𝑜𝑜𝑜𝑜𝑜  × 𝐼𝐼𝑓𝑓𝑜𝑜𝑓𝑓𝑓𝑓𝑓𝑓𝑜𝑜𝑓𝑓𝑜𝑜𝑓𝑓 + 𝐼𝐼𝑑𝑑 Equation 1-1 
where Rout = resistance to CSF outflow, Iformation = CSF formation rate and Pd = pressure in the 
dural venous sinuses, an increase in any of these factors will lead to an increase in ICP. 
Notably, any increase in cerebral venous pressure will have a direct and substantial 
influence on ICP (132). 
 
Figure 2: Cerebrospinal fluid (CSF, light blue) circulates around the brain and spinal cord and along 
nerve tracks including the optic nerve. 
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7.2.2 Intracranial Blood Circulation 
Blood supply to the brain is supported by 4 main arteries: the bilateral internal 
carotid arteries (ICA) and the bilateral vertebral arteries (VA). The VAs join together to form 
the basilar artery, which communicates with the ICAs via the posterior communicating 
arteries at the Circle of Willis. The main arteries then branch out into pial arteries, 
penetrating arteries and arterioles and eventually capillaries. On the venous side, venuoles 
and veins merge into several venous sinuses. These are contained between two layers of 
dura matter, which prevent collapsation when the venous pressure is less than the ICP. 
From the intracranial venous sinuses, cerebral venous outflow continues predominantly 
through the internal jugular veins (IJV) and vertebral veins. Interestingly, the main cerebral 
venous outflow pathway is posture dependent: majority of the venous outflow occurs in the 
IJVs in the supine position whereas at about +15° head-up tilt, the IJVs collapse, and the 
vertebral plexus overtake as the main outflow pathway (80). In contrast to the cerebral 
arterial system, the cerebral venous system can be highly asymmetric with the majority of 
individuals presenting with right lateral dominance in both the transverse sinus (4) and IJVs 
(112).  
Arterial cerebral blood flow (CBF) is highly regulated to ensure constant and 
sufficient delivery of oxygen (O2) to brain tissue. Cerebral autoregulation ensures a normal 
CBF during large fluctuations in arterial blood pressure between 60 - 140 mmHg. Below or 
above these limits, CBF decreases or increases exponentially, respectively. According to 
Ohm’s law (Equation 1-2, adapted to fluids), flow (F) is proportional to the difference in 
arterial inflow and venous outflow pressure (ΔP, Parterial - Pvenous) divided by the vascular 
resistance to flow (R): 
 
 
𝐹𝐹 =  Δ𝐼𝐼
𝑅𝑅
=  (𝐼𝐼𝑓𝑓𝑓𝑓𝑜𝑜𝑎𝑎𝑓𝑓𝑓𝑓𝑓𝑓𝑎𝑎 − 𝐼𝐼𝑣𝑣𝑎𝑎𝑓𝑓𝑜𝑜𝑜𝑜𝑣𝑣)
𝑅𝑅
 Equation 1-2 
In addition, according to Poiseuielle’s law (Equation 1-3), resistance to flow (R) is also 
related to blood viscosity (n), length of the vessel (L), and inversely related the radius of the 
vessel (r) to the fourth power: 
 
 
𝑅𝑅 =  8 × 𝑛𝑛 × 𝐿𝐿
𝜋𝜋𝑟𝑟4
 Equation 1-3 
11 
 
Thus, the radius of a vessel is the primary determinant of arterial vascular resistance and 
thus, blood flow. In addition, the cerebral vasculature is highly sensitive to changes in 
arterial partial pressure of carbon dioxide (PaCO2) and to a lesser extent, arterial partial 
pressure of oxygen (PaO2; 108). The notable effects of increased PaCO2 on cerebral vascular 
tone are driven by changes in extracellular pH; CO2 combines with water in the body to form 
carbonic acid and subsequent dissociation to form H+ ions. Although several mechanisms 
involved in the effect of pH on vascular tone have been proposed including sheer stress-
mediated release of nitric oxide and prostaglandins as well as K+ channel activation, the 
common final step is a decrease in intracellular Ca2+ concentration leading to smooth 
muscle relaxation (1, 25, 29, 49). Thus, the resulting increase in CBF helps to mitigate rising 
PaCO2 by ‘flushing’ the excess CO2 from the brain tissue. The physiological response to 
increased PaCO2 is termed cerebrovascular CO2 reactivity (1), and helps maintain central pH 
by inducing a ventilatory response through the respiratory center in the medulla. 
 
7.2.3 The Eye and Optic Nerve 
The anterior portion of the eye is filled with aqueous humor, produced by the ciliary 
body at a rate of about 3 μL/min. The central eye is composed of the lens and vitreous 
humor, a gelatinous material that does not flow, although slow diffusion can occur. The eye 
is surrounded by a rigid outer shell (the sclera), and thus any change in intraocular volume 
will result in a large change in intraocular pressure (IOP). In healthy adults, IOP averages 15 
mmHg and is predominantly determined by the resistance to outflow of aqueous humor 
through the trabecular meshwork (42), where it then drains into aqueous veins and 
episcleral veins. Posterior to the vitreous body is the retina, composed of layers of neuronal 
cells to detect and light and transmit signals. Retinal nerve fibers converge to exit the eye at 
the optic nerve head (ONH) and then form the ON. The lamina cribrosa is a lattice-like 
structure that forms a border between the intraocular and extraocular space, namely the 
retrobulbar CSF space surrounding the ON. Therefore, a pressure gradient exists across the 
lamina cribrosa, also referred to as the translaminar pressure difference (TLPD; IOP - ICP). In 
healthy adults, IOP is greater than ICP, resulting in a positive TLPD. However, any alteration 
in either ICP or IOP can alter this pressure difference and have significant effects on the 
ONH. Swelling of the ONH (papilledema), a hallmark sign in IIH patients, occurs with 
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sustained increased ICP due to compression of the ON and retinal nerve fibers and 
subsequent stasis of axoplasmic transport (120). However, other mechanisms may be 
involved including hypoxia due to compression of the pial septal blood supply to the ON or 
metabolic toxicity in the ON SAS CSF (63). On the contrary, a large TLPD can result in ONH 
cupping. This is a hallmark sign in Glaucoma patients with increased IOP, although ICP has 
also been found to be lower in patients with primary open-angle and normal-tension 
Glaucoma compared to age matched controls (18). 
The choroid, the vascular layer of the eye, lies between the retina and the sclera. The 
choroid is a dynamic structure and its thickness depends on several factors including 
intravascular volume of choroidal vessels, IOP and blood pressure (103). Several branches of 
the ophthalmic artery supply blood to the eye including the central retinal artery, and 
venous outflow occurs primarily via the vortex veins, episcleral veins and the ophthalmic 
veins. 
The ON is surrounded by the CSF-filled SAS, continuous with the SAS of the central 
nervous system. However, the ON SAS represents a unique point in the CSF circulation as 
lies outside of the rigid cranium surrounded by fatty tissue and expands with even small 
increases in CSF pressure. Notably, there is no hydrodynamic theory that can explain how 
CSF enters the ON SAS and then turns around and exits along the same route to reenter the 
CSF circulation and be reabsorbed in the venous sinuses (62). Therefore, it is likely that the 
bulk of CSF in the ON SAS is absorbed into the lymphatic system in the retrobulbar space 
(62, 65).  
 
7.3 Cerebral and Ocular Fluid Balance as a Function of Space-Related 
Environmental Factors: Mechanistic Hypothesis 
The pathophysiological mechanisms underlying the structural and functional 
ophthalmic changes in astronauts are currently unknown. However, patients with IIH, who 
normally present with an ICP > 20 mmHg, show very similar ophthalmic findings as in the 
VIIP syndrome including papilledema, globe flattening, distension of the ON sheath and 
visual loss (125). This has led to the overall hypothesis that increased ICP is the primary 
underlying mechanism causing a cascade of effects on cerebral and ocular anatomy and 
physiology in space due to disruptions in cerebral hemodynamics. Mechanistically, this 
could occur via several pathways secondary to the unique environmental conditions on the 
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ISS including headward fluid shifting due to the loss of gravitational forces with further 
exacerbation due to the addition of elevated ambient CO2 (Figure 3).  
 
7.3.1 Microgravity 
In the upright position on Earth, the Gx gravitational vector retains a large volume of 
fluid, primarily interstitial fluid and venous blood, in the lower limbs. With the abolishment 
of all gravitational gradients in microgravity, a headward fluid shift occurs (45, 93). I 
hypothesize that this leads to cerebral venous congestion with decreased cerebral venous 
outflow, predominantly in the IJVs, and increased cerebral venous pressure. As noted in 
Davson’s equation (Equation 1-1), ICP is dependent on the cerebral venous pressure, and an 
increase in cerebral venous pressure secondary to microgravity exposure will lead to a 
decrease in CSF absorption across the dural venous sinuses and result in an increase in ICP. 
Furthermore, by effect of bridging veins, which act as starling resistors affected by ICP (17), 
a vicious positive feedback loop may occur in which increased ICP will result in a decrease in 
cerebral venous return and increase intracranial blood volume, thus further exacerbating 
the elevation in ICP (123). However, due to the lack of classical symptomology associated 
with severe intracranial hypertension including chronic headache, pulse synchronous 
tinnitus or diplopia (22), the increase in ICP in microgravity may be below the clinical 
threshold, yet constantly elevated above the 24 h average ICP normally experienced on 
Earth. Overall, a small yet sustained increase in ICP secondary to microgravity exposure and 
alterations in cerebral hemodynamics could induce several cascading effects, notably 
affecting the ocular structures (Figure 3). 
As the SAS continues along the ON, increased pressure in the SAS would compress 
the optic nerve fibers and blood vessels, resulting in stasis of axoplasmic flow and ultimately 
papilledema and the formation of cotton wool spots (105). Further, as ICP is directly 
transmitted to the lamina cribrosa at the back of the eye, an increase in ICP would thus 
result in a decrease in the TLPD. Elevated pressure in the ON SAS would also exert an 
anterior force on the sclera, resulting in globe flattening and choroidal folds over extended 
exposure, ultimately leading to axial shortening and a hyperopic shift (Figure 3).  
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Figure 3: Hypothesized mechanisms underlying ocular changes in microgravity; gray-filled boxes 
represent parameters/variables measured in astronauts (32, 69, 71, 78), red boxes represent 
measurements taken in the thesis experiments and blue arrows denote a positive feedback loop; 
SAS = subarachnoid space, ON = optic nerve, CSF = cerebrospinal fluid, IOP = intraocular pressure 
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In addition, decreased cerebral venous outflow and increased cerebral venous 
pressure could also lead to increased pressure in the episcleral and vortex veins, resulting in 
decreased choroidal drainage and engorgement of the choroid. Coupled with increased 
aqueous humor outflow resistance due to the increased cerebral venous pressure, IOP 
would increase immediately. However, overtime IOP may return to baseline values through 
a compensatory decrease in aqueous humor volume. Thus, a normalized IOP coupled with 
small yet sustained increase in ICP due to disruptions in cerebral hemodynamics would lead 
to a decreased TLPD, increased pressure on the posterior eye globe and may ultimately lead 
to a cascade of ophthalmic effects in microgravity (Figure 3). Further, exposure to increased 
ambient CO2 on the ISS is hypothesized to exacerbate the microgravity-induced increase in 
ICP and the resulting effects. 
 
7.3.2 Increased Ambient Carbon Dioxide 
CO2 is known to affect many physiological systems, notably cerebrovascular 
physiology. As a potent vasodilator, exposure to elevated ambient CO2 leads to increased 
CBF, which in turn increases intracranial blood volume (37, 44, 52) and therefore ICP. On 
Earth, ambient CO2 levels average 0.04% (PCO2 of 0.3 mmHg at standard atmospheric 
pressure). As the ISS is a closed environment and it is impractical to control CO2 
concentrations to terrestrial levels, the average ambient CO2 on the ISS averages 0.1 – 0.8% 
(2.3 – 5.3 mmHg). However, there are large fluctuations over hours and days (71). In 
addition, there is no natural convection in microgravity and pockets of high CO2 levels may 
form around astronaut’s mouths in areas of low ventilation (i.e., behind a scientific rack and 
in sleeping quarters). A computational fluid dynamics analysis revealed that without 
adequate ventilation, CO2 levels could rise to 1.2% (9 mmHg) around a sleeping astronaut’s 
mouth within 10 min (110). Although exposure to 0.5-1% CO2 on Earth has not been found 
to cause significant health risks (81, 109), existing microgravity-induced alterations in 
cerebral hemodynamics and impaired cerebral venous drainage may heighten the effects of 
low level hypercapnia. Specifically, CO2-induced increases in CBF may increase cerebral 
blood volume, exacerbating the existing microgravity-induced elevation in ICP (Figure 3), 
potentially having more profound effects on astronauts with a lower cranial compliance. 
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7.4 Ground-Based Spaceflight Analog and Countermeasure Models 
7.4.1 Head-Down Tilt Bed Rest 
For decades, researches have utilized head-down tilt (HDT) bed rest as an analog 
model to simulate the effects of microgravity through head-to-foot gravitational unloading 
and inducing a cephalad fluid shift (126). Kakurin et al. (1976) conducted a 5 day bedrest at 
0°, -4°, -8°, and -12° HDT and concluded that -12° HDT best reproduced physiological 
responses to microgravity (58). However, -6° HDT was ultimately chosen for future long-
duration HDT studies as a compromise for comfort, acceptability and magnitude of 
physiological response (59). Thereafter, -6° HDT has been predominately used as a standard 
to simulate the physiological effects of microgravity on Earth and has been shown to 
reproduce many of the same effects of spaceflight (36, 119). However, ocular findings 
similar to those seen in the VIIP syndrome have not been detected during short or long-
duration HDT bed rest exposure (117), challenging the notion that -6° HDT creates a 
sufficient cephalad fluid shift to mimic that of microgravity. Furthermore, subjects in HDT 
bed rest studies have frequently used pillows to prop up their head, and therefore a strict, 
full body -6° HDT position is not maintained, but rather the head is at or even above heart 
level.  
  
7.4.2 Lower Body Negative Pressure 
Lower Body Negative Pressure (LBNP), a technique that sequesters fluid volume 
(principally venous blood) to the lower limbs, has been used for decades to research 
orthostatic tolerance, simulated blood loss and G-loading (43). LBNP devices are normally 
composed of a chamber that encompasses the legs and is sealed at the iliac crest. The 
chamber is then connected to a vacuum pump to reduce the pressure inside the chamber. 
The physiologic response to LBNP depends on both the magnitude of pressure applied and 
the duration. Low-level LBNP (-10 to -20 mmHg) approximates a reduction of centrally 
available blood volume of ~400-550 ml, whereas high-level LBNP (-20 to -40 mmHg) pulls 
~550-1000 ml of blood into the lower extremities (26). In addition, central venous pressure 
(CVP) decreases about 1-2 mmHg per 10 mmHg LBNP (94). Notably, the stronger the LBNP 
level, the greater the cardiovascular stress and the likelihood of resulting orthostatic 
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intolerance. Therefore, for long-duration use of LBNP, a low level must be implemented for 
subject comfort and feasibility.  
 
7.5 Research Aims 
As the etiology and long-term implications of the VIIP syndrome are currently 
unknown, the main aim of this thesis was to elucidate the effects of space-related 
environmental factors on intracranial and ocular anatomy and physiology, mainly cephalad 
fluid shifting and increased ambient CO2. As a secondary aim, LBNP was evaluated as a 
potential countermeasure to cephalad fluid shifting. Thus, the implemented studies 
investigated the effects of various degrees of cephalad fluid shifting, increased ambient CO2 
and LBNP on 1) cerebral hemodynamics, 2) ICP, 3) IOP and 4) cardiovascular and respiratory 
parameters as well as further effects on 5) choroid and retinal nerve fiber layer thickness, 6) 
intracranial volumes and 7) ON sheath diameter in order to decipher mechanistic pathways 
underlying the structural and functional ophthalmic changes in microgravity. The scope of 
the PhD thesis work was split into three main studies. The first study, entitled the enVIIP 
study (Section 8.1), involved a comprehensive investigation of the effects of headward fluid 
shifting on cerebral and ocular fluid and pressure balance. In Part I of the enVIIP study, 
various degrees of HDT were investigated, challenging the standard utilization of -6° HDT as 
an analog of microgravity. In Part II, as a more realistic analog to the ISS environment, an 
intermediate HDT angle (-12°) was combined with increased ambient CO2 to address the 
hypothesis of elevated CO2 exposure exacerbating headward fluid shifts and ICP. In Part III, 
continuous low-level LBNP (-20 mmHg) during HDT was tested as a means of reducing 
cerebral venous congestion as a countermeasure to headward fluid shifting. The next study 
(the SpaceCOT Study - Section 8.2) built upon the results of the enVIIP study and 
investigated a longer duration exposure to -12° HDT (29 h) with and without increased 
ambient CO2 as a potential new model for ground-based analog studies. Finally, the SETI 
study (Section 8.3) was designed to elucidate the effects of exposure to a stronger level of 
LBNP (-40 mmHg) for shorter durations of time with an extended range of tilt angles. The 
main findings and their significance are discussed in Section 9, with conclusions and future 
perspectives presented in Section 10. 
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8 Experiments 
 
All studies were conducted in the envihab facility at the Institute of Aerospace 
Medicine, German Aerospace Center (DLR) in Cologne, Germany. Subjects were recruited 
from an internal database of subjects as well as through social medial and university website 
platforms. Written and informed consent was obtained from all subjects prior inclusion in 
experiments. All studies were conducted in accordance with the ethical principles in the 
Declaration of Helsinki and were approved by the local ethics commission, Ärztekammer 
Nordrhein [Appendix Documents A1, A2 and A3 for the enVIIP study, SpaceCOT study and 
SETI study, respectively]. 
 
8.1 The enVIIP Study: Cerebral and Ocular Fluid Balance as a Function of 
Hydrostatic Pressure Gradients and Environmental Factors 
 
8.1.1 Study Design 
The enVIIP study was a randomized, cross-over design, 3-part study consisting of a 
total of 5 experimental HDT conditions (Figure 4). In Part I, three HDT angles were 
investigated: -6°, -12° and -18° HDT. In Part II, an intermediate HDT angle (-12°) was 
combined with an increased ambient CO2 (1%) as a more realistic model of the ISS 
environment. In Part III, low level LBNP (-20 mmHg) was implemented during -12° HDT as a 
potential countermeasure to headward fluid shifting. Baseline data was collected before 
each HDT condition in the supine (0°) position, followed immediately by 5 h in the HDT 
position. Each intervention experiment was performed on a separate day, with at least one 
week between experimental conditions to minimize carry-over effects.  
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Figure 4: The enVIIP study consisted of 5 experimental conditions. Each condition included 3 h of 
baseline data collection (BDC) in the supine position followed by 5 h of head-down tilt (HDT). There 
was a separate visit for each of the five conditions, with at least one week break between 
experimental conditions. 
 
In the 24 h preceding each experiment, subjects were instructed to consume 40 ml 
of water per kg body weight and to refrain from caffeinated beverages. All fluid and 
nutritional intake was standardized for the study as well. On the experimental days, subjects 
arrived fasted and were provided a standardized breakfast in addition to 250 ml of water 
and 200 ml of juice. After 3 h of baseline data collection in the supine position, subjects 
received 250 ml of water and a standardized snack before proceeding directly into HDT. 
After 2.5 h HDT, subjects received a high caloric shake (200 ml). Urination breaks were set at 
pre-determined time points and kept consistent across experimental conditions. 
 
8.1.2  Subjects 
Nine healthy, male subjects (mean ± SD, age: 25 ± 2 yrs; height: 183 ± 6 cm; weight: 
81 ± 11 kg) were enrolled in the randomized cross-over design study. All subjects underwent 
a basic medical examination prior to inclusion in the study including a medical history and 
current health status interview, physical examination, urine and blood samples, spirometry 
test, electrocardiogram and eye examination. Subject inclusion criteria included male 
subjects between the ages of 18 – 65 and body mass index (BMI) between 26 – 30 kg/m2. 
Subject exclusion criteria included current prescription medication usage, smoking, IOP > 20 
mmHg, more than +5 or -6 diopters, history of abnormal IOP or diseases of the ON, history 
of increased ICP or any neurological or cardiovascular disease. 
BDC
HDT
-6° HDT -12° HDT -18° HDT
-12° HDT 
+ 1% CO2
-12° HDT 
+ LBNP
20 
 
8.1.3  Materials and Methods 
An example time table from the enVIIP study showing various measurement time 
points is displayed in the Appendix (Table A 1).  
 
Intraocular and Intracranial Pressure Measurements 
IOP was measured with an Icare pro tonometer (Icare, Helsinki, Finland) at supine 
baseline and after 3.5 h HDT. At each measurement time point, IOP was measured 3 times 
in each eye in a randomized order. The median value was then used for statistical analysis. 
ICP was measured with a non-invasive ICP meter (Vittamed, Kaunas, Lithuania). Using 
transcranial Doppler (TCD) ultrasound, blood flow pulsations in two segments of the 
ophthalmic artery, one extracranial and one intracranial, are measured simultaneously. An 
external pressure cuff on the orbital tissue is then inflated to 6 pressure steps (4, 8, 12, 16, 
20 and 24 mmHg), and at the optimal external pressure, the balance point between the two 
arteries is found (100). ICP was measured at supine baseline and again after 3.5 h HDT, with 
1-2 measurements taken at each time point.  
 
Spectral Domain Optical Coherence Tomography  
Spectral Domain Optical Coherence Tomography (SD-OCT) is currently the gold 
standard technique for quantifying tissue layers in the eye, emitting multiple wavelengths of 
light and measuring the reflected light to produce detailed cross-sectional images of the 
retina and choroid. An SD-OCT (Spectralis, Heidelberg Engineering, Heidelberg, Germany) 
with automatic real time (ART) TruTrack technology was implemented in the study. The 
TruTrack image alignment software allows for real time eye movement tracking and aligns 
scans with the original baseline image to ensure subsequent scans are taken in the exact 
same position.  
For visualization of the choroid, a line scan with enhanced depth imaging (EDI, scan 
parameters: IR&OCT 30° ART EDI [HS] ART(100) Q:37) was taken through the fovea and ONH 
(Figure 5A). Custom-built software was then used to enhance the choroid for better 
visualization (Figure 5C) and to delineate the boundaries of the retina and choroid in a semi-
automated process (Figure 5D, software courtesy of Dr. Nimesh Patel). The point of the 
fovea was determined by the thinnest section of the retina, and the thickness of the choroid 
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underneath was measured (average taken of 250 μm of choroid under the fovea). One 
subject was excluded from analysis due to a very thick choroid and unclear delineation of 
the posterior choroid border.  
 
Figure 5: A) The SD-OCT line scan was taken through the fovea and optic nerve head across the 
posterior eye globe resulting in (B) an image of the retinal nerve fiber layers, choroid and sclera. C) 
For image processing and analysis, the choroid was enhanced and D) semiautomatic delineations 
were made of the inner limiting membrane (green line), the hyper-reflective retinal pigment 
epithelium (yellow line) and the inner surface of the sclera (red line).  
 
In addition, a circle scan (scan parameters: IR&OCT 30° ART [HS] ART(100) Q:34) 
around the ONH was taken to measure the peri-ONH retinal nerve fiber layer (RNFL) 
thickness (Figure 6). The RNFL boundaries were automatically delineated with the Heyex 
software (Heidelberg Eye Explorer Version 3.1, Heidelberg Engineering, Heidelberg, 
Germany) and the global RNFL thickness was calculated. All SD-OCT scans were taken in the 
right eye on a custom-built platform allowing for measurements to be made in the upright 
(head tilted), supine and HDT positions (Appendix Figure A 1). Scans were taken at baseline 
in both the upright and supine positions and again after 1.5 h and 3 h HDT. 
A B
C
D
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Figure 6: A circle SD-OCT scan was positioned around the optic nerve head (A), imaging the 
underlying layers (B). 
 
Magnetic Resonance Imaging 
MRI data was acquired with a Siemens Biograph mMR 3-T scanner (Siemens, 
Erlangen, Germany) with a 16 channel head coil. The total duration of the MR scan was 
about 1 hour. Baseline scans were taken in the supine position before each experimental 
condition, and intervention scans were taken between the 4-5th h of HDT. During HDT, all 
five experimental conditions were maintained within the MRI scanner. Custom-built wedges 
in the -6°, -12° and -18° positions were implemented within the scanner. For the 1% 
ambient CO2 condition, a MR-compatible mask and tank system was designed for use inside 
the scanner as well. Lastly, a MR-compatible LBNP system was designed in the -12° HDT 
position (Appendix Figure A 2). 
3D Volumetric MRI: After localization scans, a 3D volumetric T1-weighted MPRAGE 
(magnetization-prepared rapid acquisition of gradient echo) scan was acquired for a 
volumetric assessment of the CSF, gray matter (GM) and white matter (WM). The following 
scan parameters were implemented: acquisition time (TA) 9:20 min, repetition time (TR) 
2500 ms, echo time (TE) 4.82 ms, inversion time (TI) 1100 ms for fat suppression, flip angle 
7°, bandwidth 140 Hz/Px. The field-of-view (FOV) covered 256 mm with an isotropic 
resolution of 1 mm. The images were analyzed using voxel-based morphometry with the 
VBM8 toolbox from the SPM8 software package (http://www.fil.ion.ucl.ac.uk/spm). After 
field bias correction and registration to a common space, the tissue was segmented into 
A B
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GM, WM and CSF and volumes were calculated. Large vessels such as the internal carotid 
arteries were excluded from segmentation.  
Orbital Scans: In addition, T2-weighted transverse scans of the eye globe and ON 
were also obtained for the right and left eye (Figure 7A). A turbo spin echo (TSE) sequence 
with spectral attenuated inversion recovery (SPAIR) fat suppression was used with the 
following parameters: TA 3:02 min, TR 3000 ms, TE 103 ms, flip angle 180°, bandwidth 395 
Hz/Px. The FOV covered 96*96 mm with a 129*128 matrix, which resulted in a resolution of 
0.75 mm. The matrix was interpolated in 258 * 256 with a 0.375 mm resolution. A 100% 
phase oversampling was utilized to avoid fold-in artefacts. Parallel imaging with an 
acceleration factor of 2 was enabled (GRAPPA algorithm). The slab consisted of 30 slices 
with a slice thickness is 1.56 mm and 2 averages were obtained. A custom-built Matlab 
software (Release 2012b, The MathWorks Inc., Natick, Massachusetts, USA) was used to 
measure the diameter of the ON sheath 3, 4 and 5 mm behind the eye globe (Figure 7B).  
 
 
Figure 7: A) Transverse T2-weighted MR images of the eye globe and optic nerve were obtained 
during all conditions. B) Using custom-built software, the optic nerve sheath diameter was measured 
3, 4 and 5 mm behind the posterior globe. 
 
Phase-Contrast MRI: A flow sensitive MRI technique, phase-contrast MRI (PC-MRI), 
was implemented to measure cross-sectional area (CSA) and blood flow velocity in the 
major arteries and veins of the neck, allowing for flow to be calculated. When a strong 
magnetic field is applied, proton spins align parallel and anti-parallel to the axis of the 
external field. With the addition of radio frequency energy (90° pulse), a small surplus of 
spins excite orthogonally and are set in phase. In PC-MRI, the effect of ‘phase shift’ (the 
change in the moving protons’ axis of spin) and its proportionality to the protons’ velocity is 
A B
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utilized (74). Thus, stationary tissue contrasts from flowing fluid where the signal is linearly 
proportional to the velocity of the spins (faster spins produce a larger phase shift) (111). In 
addition, direction can be determined. In gray-scaled images, for example, stationary tissue 
is typically coded in gray, spins moving in one direction are coded in white and spins moving 
in the opposite direction in black. Thus, the vascular anatomy (magnitude image, Figure 8A) 
and the velocity and direction of flow (phase image, Figure 8B) can be quantitatively 
displayed. The 3D MPRAGE scan was used for planning of the perpendicular PC-MRI plane 
above the bifurcation of the carotid artery. The bilateral internal carotid arteries (ICA), 
vertebral arteries (VA) and IJVs were measured between the second and third cervical 
vertebrae. 
 
 
Figure 8: An anatomical (magnitude) image (A) and velocity (phase) image (B) from phase contrast-
MRI scans taken between the second and third cervical vertebrae showing the bilateral internal 
jugular veins (blue arrows), internal carotid arteries (solid red arrows) and vertebral arteries (dashed 
red arrows) 
  
PC-MRI scans were obtained with the following parameters: total TA (heart-rate 
dependent): 7-11 min, TR 21.4 ms, TE 6.71 ms, slice thickness 5 mm, 15° flip angle, 200 × 
200 mm field of view, 320 × 320 acquisition matrix, 0.625 × 0.625 mm in-plane resolution 
with 32 calculated phases and two averages. Parallel imaging with a GRAPPA algorithm 
acceleration factor 2 was used with 24 reference lines. The velocity encoding value was 70 
cm/s and retrospective peripheral pulse gating was used. Image analysis and post 
A. B.
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processing was conducted with Segment v1.8 software 
(http://medviso.com/products/segment). A region of interest was drawn manually to 
delineate the lumen of the artery/vein, and an automated, contour-active model was then 
used to track the boundaries during the cardiac cycle (46). Blood flow was also calculated by 
multiplying the CSA (cm2) by the blood flow velocity (cm/s) of the vessel. Total CBF was 
calculated as the sum of the mean blood flow through the bilateral ICAs and VAs and the 
total jugular venous outflow was calculated as the sum of the mean blood flow through the 
bilateral IJVs. 
 
Cardiovascular and Respiratory Measurements 
Several cardiovascular parameters were measured at baseline and after 1, 2, 3 and 4 
h HDT during the various HDT conditions. Beat-by-beat mean arterial pressure (MAP), 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured 
continuously for 10 min with a Finometer (Finapres Medical Systems, Amsterdam, The 
Netherlands). In addition, subjects were donned with a 3-lead electrocardiogram to 
measure beat-by-beat heart rate (HR) (Biopac Systems, Goleta, California, USA). Respiratory 
parameters including end tidal CO2 and minute ventilation were measured at supine 
baseline and after 3 h HDT with the Innocor system (Innovision, Odense, Denmark). Subjects 
breathed into the Innocor mouthpiece continuously for 10 min at each each measurement 
time point, with the last 5 min used for statistical analysis. 
 
Statistical Analysis 
Analysis of variance (ANOVA) and linear mixed effect models were created with time 
(baseline vs. HDT) and condition (-6°, -12°, -18°, -12° + 1% CO2 and -12° + -20 mmHg LBNP) 
as main effects, allowing for a time-condition interaction, and subject ID as a random effect. 
For measurements taken bilaterally (IOP, PC-MRI, ONSD), side was included as an additional 
term to determine the effect of lateralization. The level for statistical significance was set to 
α = 0.05 and β was set to 0.2. When main effects were found to be statistically significant, 
Bonferroni post-hoc analyses were implemented for further comparison. All data are 
presented as mean and standard deviation (SD) in the tables and shown as mean and 
standard error of the mean (SEM) in the figures to demonstrate uncertainty. Statistical 
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analyses were carried out with R (version 3.1.2, 64-bit, www.r-project.org) in the R-studio 
environment (version 0.98.1049). 
 
8.1.4 Results 
Intraocular Pressure* 
IOP was found to have significant main effects of time (F(1,158) = 132.2, p < 0.001) 
and condition (F(4,158) = 10.97, p < 0.001) with a significant time-condition interaction 
(F(4,158) = 7.4, p < 0.001). In addition, a trend towards significance was found for eye 
lateralization as a main effect (F(1,158) = 3.6, p = 0.06). Post-hoc analysis revealed that after 
3.5 h HDT, IOP increased from supine baseline (average of 15.3 ± 0.1 mmHg) to 17.9 ± 0.4 
mmHg during -12° HDT (p < 0.001) and 18.7 ± 0.4 mmHg during -18° HDT (p < 0.001, Figure 
9). However, IOP was unchanged from supine baseline during -6° HDT (16.3 ± 0.3 mmHg, p = 
0.6). When comparing the HDT conditions, IOP increased step-wise from -6° to -12° HDT (p < 
0.001) and further from -12° to -18° HDT (p = 0.02). The addition of a 1% CO2 air mixture 
during -12° HDT resulted in a small decrease in IOP compared to -12° HDT plus ambient air 
(p < 0.001), although IOP was still increased compared to baseline in both conditions (Figure 
9). IOP remained increased from 0° baseline with the addition of -20 mmHg LBNP during -
12° HDT, with no further change from -12° HDT alone (p = 0.2).  
                                                     
 
 
* Intraocular pressure results from the enVIIP study have been published (84) 
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Figure 9: Intraocular pressure (IOP) at 0° baseline and during various head-down tilt (HDT) 
conditions, * p < 0.05, *** p < 0.001 
 
Intracranial Pressure† 
Significant main effects of time (F(1,146) = 29.7, p < 0.001) and condition (F(4,146) = 
7.6, p < 0.001) were found for ICP, with a significant time-condition interaction (F(4,146) = 
6.9, p < 0.001). Mean ICP during supine baseline was found to be 9.6 ± 0.3 mmHg. Post-hoc 
analysis revealed that ICP increased to 14.4 ± 1 mmHg after 3.5 h exposure to -18° HDT (p < 
0.001), however, was not found to increase significantly during -6° or -12° HDT (p = 0.9 and 
p = 0.4, respectively; Figure 10). The addition of a 1% CO2 environment during -12° HDT had 
no further effects on ICP compared to -12° HDT alone (p = 0.7). Further, -20 mmHg LBNP 
during -12° HDT had no further effects on ICP compared to -12° HDT without LBNP (p = 0.6). 
 
                                                     
 
 
† Intracranial pressure results from the enVIIP study have been published (84) 
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Figure 10: Intracranial pressure (ICP) at supine baseline and during various head-down tilt (HDT) 
conditions, *** p < 0.01 
 
  
Optical Coherence Tomography: Choroidal and Retinal Nerve Fiber Layer Thickness 
Mean sub-foveal choroidal thickness and global RNFL thickness measured in the 
upright and supine baseline positions and again after 1.5 and 3 h HDT are shown in Table 2. 
No significant main effects of time or condition were found for sub-foveal choroidal 
thickness (F(3,151) = 1.4, p = 0.26, and F(4,151) = 0.85, p = 0.5, respectively). Global 
periorbital RNFL thickness had a significant main effect of condition (F(4,150) = 4.5, p = 0.02) 
but not time (F(3,150) = 1.6, p = 0.18). No significant time-condition interactions were 
found. 
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Table 2: Mean sub-foveal choroidal thickness and global retinal nerve fiber layer (RNFL) thickness 
during upright and supine baseline measures and after 1.5 h and 3 h head-down tilt (HDT) during 
various conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Phase Contrast Magnetic Resonance Imaging: Cross-Sectional Area, Blood Flow 
Velocity and Blood Volume Flow‡ 
PC-MR images were analyzed for 4/5 HDT conditions. The -12° HDT plus LBNP 
condition had to be excluded from analyses due to significant motion artifacts in 7/9 
subjects.  
Cross-Sectional Area and Blood Flow Velocity: On the arterial side, ICA CSA was found 
to have a main effect of time (F(1,124) = 12.3, p < 0.001) increasing slightly during -18° HDT 
compared to baseline (0.27 ± 0.03 cm2 vs. 0.21 ± 0.01 cm2, p < 0.01, Figure 11). In addition, a 
main effect of time (F(1,124) = 69.5, p < 0.001) and condition (F(3,124) = 3.4, p = 0.02) was 
found for ICA blood flow velocity. A decrease in ICA blood flow velocity was found during all 
                                                     
 
 
‡ Phase contrast-MRI results from the enVIIP study have been published (83) 
Condition 
Time Point 
Baseline 
(upright) 
Baseline 
(supine) 
1.5 h HDT 3 h HDT 
 Sub-foveal Choroidal Thickness (μm) 
-6° HDT 389 ± 70 403 ± 88 398 ± 83 400 ± 82 
-12° HDT 388 ± 73 391 ± 76 398 ± 73 391 ± 82 
-18° HDT 396 ± 83 392 ± 78 401 ± 77 403 ± 85 
-12° HDT+ 1% CO2 397 ± 86 399 ± 76 395 ± 87 401 ± 80 
-12° + -20 mmHg LBNP 394 ± 91 399 ± 85 393 ± 76 391 ± 84 
 Global RNFL Thickness (μm) 
-6° HDT 98 ± 7 98 ± 7 98 ± 7 98 ± 7 
-12° HDT 97 ± 6 98 ± 6 98 ± 7 98 ± 6 
-18° HDT 97 ± 7 98 ± 6 98 ± 7 99 ± 6 
-12° HDT+ 1% CO2 98 ± 7 99 ± 6 98 ± 6 98 ± 6 
-12° + -20 mmHg LBNP 98 ± 7 98 ± 7 98 ± 7 99 ± 7 
 
Data presented as mean ± SD, LBNP = Lower Body Negative Pressure 
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HDT angles from 22.4 ± 0.5 cm/s at baseline to 18.3 ± 1.4 cm/s at -6° (p = 0.01), 15.1 ± 1.2 
cm/s at -12° (p < 0.001), 20 ± 1.6 cm/s at -12° with 1% CO2 (p = 0.04), and 16 ± 1.2 cm/s at -
18° HDT (p < 0.001, Figure 12). No change in total VA CSA or blood flow velocity was found.  
 
 
Figure 11: Cross-sectional area (CSA) of the internal jugular veins (blue), internal carotid arteries (red 
circles) and vertebral arteries (red triangles) during various head-down tilt (HDT) conditions, # p < 
0.1, * p < 0.05, ** p < 0.01, *** p < 0.001 
 
On the venous side, IJV CSA was found to have a significant main effect of time 
(F(1,116) = 44.9, p < 0.001), increasing from an average baseline of 0.304 ± 0.02 cm2 at 
baseline to 0.54 ± 0.08 cm2 during -12° (p < 0.001) and 0.62 ± 0.08 cm2 during -18° HDT (p < 
0.001; Figure 11). IJV CSA also increased from baseline to 0.48 ± 0.07 cm2 during -12° HDT 
with 1% CO2 (p = 0.04). With the HDT-induced increase in IJV CSA also came a significant 
main effect of time for IJV blood flow velocity (F(1,116) = 25.9, p < 0.001): IJV blood flow 
velocity decreased from an average of 14.9 ± 0.9 cm/s at baseline to 8.1 ± 1.3 cm/s during -
12° (p < 0.001) and to 8.9 ± 1.8 cm/s during -18° HDT (p = 0.002, Figure 12). 
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Figure 12: Blood flow velocity of the internal jugular veins (blue), internal carotid arteries (red 
circles) and vertebral arteries (red triangles) during various head-down tilt (HDT) conditions, * p < 
0.05, ** p < 0.01, *** p < 0.001 
 
Blood volume flow: Blood flow was automatically calculated by multiplying the 
velocity by the CSA for each vessel. Total arterial inflow is defined as the sum of the mean 
flow of the bilateral ICAs and VAs and the total jugular venous outflow is defined as the sum 
of the mean flow of the bilateral IJVs. Total arterial inflow was found to have a significant 
main effect of time (F(1,53) = 51.7, p < 0.001) and a trend towards significance for condition 
(F(3,53) = 2.4, p = 0.07). Total arterial inflow decreased from baseline during -6°, -12°, and -
18° HDT (p < 0.05, p < 0.001 and p = 0.002, respectively, Figure 13). Interestingly, the 
maximum decrease was seen at -12° HDT compared to the average baseline (606 ± 40 
ml/min vs. 782 ± 16 ml/min, respectively).  
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Figure 13: Total arterial inflow (red) and total internal jugular venous outflow (blue) during various 
head-down tilt conditions, * p < 0.05, ** p < 0.01, *** p < 0.001 
 
Furthermore, the addition of 1% CO2 during -12° HDT increased total arterial inflow 
compared to -12° HDT alone (p = 0.02), however, remained below baseline values (p = 0.02). 
The relative contribution of the ICAs versus VAs to total arterial inflow was consistent across 
all conditions with an average of 69% and 31%, respectively. Total internal jugular venous 
outflow was found to have a significant time-condition interaction (F(3,47) = 2.9, p = 0.046), 
with a decrease from baseline during -12° HDT (p = 0.039). In addition, an increase in total 
venous outflow was seen when going from -12° to -18° HDT (p = 0.01). Furthermore, in a 
similar manner to the total arterial inflow, total jugular venous outflow increased during -
12° HDT with 1% CO2 compared to -12° HDT alone (p < 0.01). Notably, there was a strong 
effect of lateralization, with 6/8 subjects having higher mean blood volume flow through the 
right IJV compared to the left. 
 
Volumetric Magnetic Resonance Imaging: Cerebrospinal Fluid, Gray Matter and 
White Matter Volumes  
Volumes for CSF, GM and WM were calculated and analyzed separately. For CSF 
volume, a main effect of time (F(1,71) = 21.5, p < 0.001) and a trend towards significance for 
condition (F(4,71) = 2.2, p = 0.073) were found. There was a small increase from 259 ± 10 ml 
at baseline to 264.4 ± 11 ml during -12° HDT (p = 0.01), however no significant change from 
baseline during any other HDT condition (Table 3). Notably, compared to -12° HDT, there 
was a trend towards significance with the addition of LBNP during -12° HDT, decreasing the 
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CSF volume to 260 ± 9.3 ml (p = 0.055). WM volume was found to have a significant main 
effect of condition (F(4,71) = 2.7, p = 0.04), with increased white matter volume during -12° 
HDT with LBNP compared to -12° HDT alone (579.6 ± 7.9 ml and 571.6 ± 8.6 ml, respectively, 
p < 0.001). GM volume was found to have a significant main effect of time (F(1,71) = 6.5, p = 
0.013). However, both GM and WM volume displayed variations in baseline values (Table 3). 
 
Table 3: MRI-derived cerebrospinal fluid (CSF), white matter and gray matter volumes at supine 
baseline (BDC) at during various head-down tilt (HDT) conditions 
 
 Time Point 
Condition BDC HDT 
  CSF Volume (ml) 
-6° 261 ± 28 264 ± 29 
-12° 259 ± 30 264 ± 31* 
-18° 258 ± 29 262 ± 31 
-12° HDT + 1% CO2 258 ± 30 261 ± 28 
-12° HDT + LBNP 257 ± 28 260 ± 26 
 White Matter Volume (ml) 
-6° 577 ± 20 571 ± 23 
-12° 569 ± 24 572 ± 24 
-18° 571 ± 19 571 ± 23 
-12° HDT + 1% CO2 575 ± 19 571 ± 22 
-12° HDT + LBNP 574 ± 21 580 ± 22 
  Gray Matter Volume (ml) 
-6° 718 ± 54 730 ± 52* 
-12° 729 ± 50 726 ± 51 
-18° 729 ± 47 731 ± 50 
-12° HDT + 1% CO2 724 ± 54 732 ± 52 
-12° HDT + LBNP 721 ± 57 729 ± 54 
 
Data presented as mean ± SD, LBNP = lower body negative pressure, * p < 0.05 
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Optic Nerve Sheath Diameter 
Optimal transverse slices of the right and left ON were chosen for analyses. ONSD 
was measured 3, 4 and 5 mm posterior to the eye globe (Table 4).  
 
Table 4: Optic nerve sheath diameter at 3, 4 and 5 mm posterior to the eye globe at baseline (0°) 
and after 4 h head-down tilt (HDT) in various conditions 
 
Condition 
Measurement Point (Distance Behind Eye Globe) 
3 mm 4 mm 5 mm 
0° 5.96 ± 0.62 5.82 ± 0.59 5.5 ± 0.53 
-6° HDT 6.26 ± 0.54*** 6.20 ± 0.66*** 5.87 ± 0.65*** 
-12° HDT 6.32 ± 0.54*** 6.24 ± 0.52*** 5.86 ± 0.44*** 
-18° HDT 6.51 ± 0.57*** 6.35 ± 0.62*** 5.94 ± 0.6*** 
-12° HDT + 1% CO2 6.29 ± 0.54** 6.20 ± 0.59*** 5.82 ± 0.53*** 
-12° HDT + LBNP 6.16 ± 0.63 6.01 ± 0.64* 5.64 ± 0.6 
 
Data presented as mean ± SD, LBNP = lower body negative pressure, * p < 0.05, ** p < 0.01, *** p 
< 0.001 
 
ONSD measured 3 mm behind the eye globe are additionally presented in Figure 14, 
as this is the standard measurement distance in literature. ONSD had a significant main 
effect of time (F(1,159) = 95, p < 0.001) and condition (F(4,159) = 2.5, p = 0.045) with a 
significant time-condition interaction (F(4,159) = 2.9, p = 0.02) when measured 3 mm behind 
the globe. However, eye lateralization was not significant (p = 0.3). ONSD was found to 
increase from baseline during -6° (p < 0.001), -12° (p < 0.001), and -18° HDT (p < 0.001, 
Figure 14), with subsequent increase from -12° to -18° HDT (p = 0.02).The addition of a 1% 
CO2 atmosphere to -12° HDT, however, had no further effects on ONSD compared to -12° 
HDT with ambient atmosphere (p = 0.66). Interestingly, the addition of -20 mmHg LBNP 
decreased ONSD compared to -12° HDT alone (p = 0.03), however ONSD was still slightly 
increased (trend towards significance) compared to supine baseline (p = 0.08, Figure 14).  
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Figure 14: Optic nerve sheath diameter (ONSD) measured 3 mm behind the eye globe at 0° baseline 
and during various head-down tilt (HDT) conditions, LBNP = lower body negative pressure, * p < 
0.05, ** p < 0.01, *** p < 0.001 
 
Cardiovascular and Respiratory Parameters§ 
A significant main effect of time was found for MAP (p = 0.046), DBP (p < 0.001), SBP 
(p < 0.001) and HR (p = 0.026), and a significant main effect of condition was found for MAP 
(p < 0.001), DBP (p = 0.01) and HR (p < 0.001). Post hoc comparisons to baseline are shown 
in Table 5. No time-condition interactions were found to be significant for any 
cardiovascular parameter.  
  
                                                     
 
 
§ Cardiovascular and respiratory parameters from the enVIIP study have been published (83, 84) 
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Table 5: Cardiovascular parameters measured at baseline (BDC) and after 1 h, 2 h, 3 h and 4 h head-
down tilt (HDT) during various conditions 
 
 
Time Point  
Condition BDC 1 h HDT 2 h HDT 3 h HDT 4 h HDT 
 
Mean Arterial Pressure (mmHg) 
-6° 73.2 ± 10.8 77.4 ± 12.7 79.6 ± 11.0 82 ± 15.3 87.9 ± 11.2*** 
-12°  75.3 ± 13.7 79.4 ± 9.2 78.5 ± 13.5 81.8 ± 17 84.7 ± 14.3 
-18° 71 ± 7.2 74 ± 7.8 78.5 ± 14.6 84.3 ± 8.4** 82.1 ± 10.8* 
-12° + 1% CO2 76.9 ± 12.1 77.3 ± 10.4 79.9 ± 7.9 81.4 ± 7.7 84 ± 12.2 
-12° + LBNP 73.6 ± 6.3 81.1 ± 9.4 83.4 ± 10.4 89.1 ± 12.1*** 92.9 ± 10.5*** 
 
Systolic Blood Pressure (mmHg) 
-6° 123.3 ± 17.4 127.7 ± 13.9 129.6 ± 12.9 135.8 ± 19.8 141 ± 14.7** 
-12°  125.3 ± 9.9 126.1 ± 14.1 128.1 ± 15.6 135.4 ± 18.7 138.2 ± 15.9 
-18° 124.7 ± 11.4 121 ± 16 126.5 ± 16.9 134.1 ± 15.5 131.5 ± 20.3 
-12° + 1% CO2 134.4 ± 14.7 125.4 ± 12.9 128.1 ± 14.1 132.4 ± 11.8 135.9 ± 16 
-12° + LBNP 127.3 ± 11.5 127.4 ± 10.5 130.3 ± 14.7 140.8 ± 12.8 140.8 ± 13.6 
 
Diastolic Blood Pressure (mmHg) 
-6° 56.3 ± 9 60.1 ± 11.6 63.1 ± 9.4 64.1 ± 12.9 68.7 ± 9.7** 
-12°  58.8 ± 13.4 63.4 ± 8.1 61.4 ± 12.8 63.6 ± 16.8 66.1 ± 13.2 
-18° 53.3 ± 6.8 58.5 ± 7.2 62.2 ± 12.1 67.2 ± 7.9** 65 ± 9.1* 
-12° + 1% CO2 59.3 ± 11.4 61.4 ± 9.6 63.3 ± 6.8 64.2 ± 7.7 66.5 ± 10.5 
-12° + LBNP 57.2 ± 6.1 65.6 ± 9.6 66.6 ± 9.5 70.9 ± 12.2** 75.3 ± 10.7*** 
 
Heart Rate (BPM) 
-6° 61.9 ± 9.7 59.5 ± 7.9 60.1 ± 8.9 60 ± 7.7 60.8 ± 8.1 
-12°  65.1 ± 8.8 62.4 ± 9.3 59.7 ± 9.4 60.6 ± 10.7 63.3 ± 11.7 
-18° 59.8 ± 8.2 57.6 ± 6.7 58 ± 7.4 59 ± 6.3 58 ± 9.3 
-12° + 1% CO2 60.1 ± 9.6 58.4 ± 9.8 58.6 ± 6.5 55.7 ± 9.4 60.4 ± 11.9 
-12° + LBNP 61.9 ± 10.7 61.4 ± 9.9 58.7 ± 10.2 59.4 ± 12 62.6 ± 13.1 
 
Data presented as mean ± SD, LBNP= lower body negative pressure, BPM = beats per minute, * p < 
0.05, ** p < 0.01, *** p < 0.001 
 
Respiratory parameters are shown in Table 6. End tidal CO2 had a significant time-
condition interaction (F(4,77) = 4.2, p = 0.004) and post-hoc analysis revealed increased end 
tidal CO2 during -12° HDT with 1% CO2 compared to -12° HDT with ambient air (p = 0.004). 
No significant main effects were found for minute ventilation.  
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Table 6: Respiratory parameters at supine baseline (BDC) and after 3 h head-down tilt (HDT) during 
various conditions 
 
Time Point 
Condition BDC HDT 
  ETCO2 (%) 
-6° 5.14 ± 0.74 4.52 ± 0.56 
-12°  4.98 ± 0.96 4.76 ± 0.87 
-18° 4.8 ± 0.97 4.67 ± 0.75 
-12° + 1% CO2 4.8 ± 0.68 5.23 ± 0.75 
-12° + LBNP 4.87 ± 0.8 4.8 ± 0.56 
  Minute Ventilation (l/min) 
-6° 7.96 ± 3.12 8.17 ± 2.75 
-12°  9 ± 3.02 9.51 ± 3.66 
-18° 8.52 ± 3.97 8.8 ± 4.2 
-12° + 1% CO2 8.51 ± 3.98 8.17 ± 3.45 
-12° + LBNP 8.26 ± 3.31 8.66 ± 3.17 
 
Data presented as mean ± SD, ETCO2 = end tidal CO2, LBNP = lower body negative pressure 
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8.2 The SpaceCOT Study: Studying the Physiological and Anatomical Cerebral Effects 
of CO2 and Tilt on Intracranial and Intraocular Pressure 
8.2.1  Study Design** 
The SpaceCOT study was an internationally collaborative study between several 
institutions (a full list of investigators and institutions is provided in the Appendix, 
Document A 4). The study consisted of a randomized, double-blinded cross-over design with 
two conditions: 26 h -12° HDT with ambient air and 26 h -12° HDT with 0.5% CO2 (Figure 15). 
The two HDT conditions exhibited identical study procedures, with the exception that prior 
to baseline data collection on day 1 (before the first condition), subjects came in one day 
early for a familiarization session to be introduced to all experimental techniques and the 
timeline of the study. Baseline data was collected in the seated, upright position, followed 
by a random HDT condition the following day. Atmospheric conditioning is possible in the 
entire bedrest module of the envihab facility (all bedrooms, bathrooms and common 
spaces) and was monitored by an independent operator, allowing for the condition to be 
blinded. In addition, after 26 h HDT (and while still in the -12° HDT position), subjects were 
exposed to a 3% CO2 atmosphere through a mask and tank system for 3 h to determine the 
effects of short-term exposure to a high CO2 concentration, similar to what astronauts may 
experience in areas with poor ventilation on the ISS. 
                                                     
 
 
** The SpaceCOT study design and Figure 15 are included in paper #3 from section 11.1 (currently in revision) 
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Figure 15: The SpaceCOT study consisted of a randomized, cross-over design with two campaigns: 
the first campaign included a familiarization session followed by a full day of baseline data collection 
(BDC) and then 29 h of -12° head-down tilt (HDT) with either ambient air of 0.5% CO2. After a one 
week washout period, the subjects returned for the second campaign consisting of a full day of BDC 
followed by 29 h of -12° HDT with either 0.5% CO2 or ambient air. 
 
During the full 29 h of bedrest, all subjects strictly adhered to the -12° HDT position 
(including during all daily activities such as eating, washing and going to the bathroom). 
Subjects were allowed to lie on their side, however, one shoulder was in contact with the 
mattress at all times (sitting or standing not permitted). Nutritional intake was controlled 
and standardized according to well-established formulas issued by the World Health 
Organization (135). The presented findings from the SpaceCOT study represent a subset of 
results from the larger collaborative study. A complete timeline of all measurements in the 
study is provided in Table A 2 of the Appendix. 
 
8.2.2  Subjects 
Six healthy, male subjects (mean ± SD age: 41 ± 5 y, height: 177 ± 4 cm and weight: 
82 ± 8 kg) were enrolled in the study. Prior to inclusion in the study, all subjects underwent 
a comprehensive medical examination including psychological questionnaire, oral medical 
history interview, blood and urine samples, resting and stress electrocardiogram (through 
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cycle ergometer exercise), an eye examination, a stand test for orthostatic tolerance and 
thrombosis screening. In addition, subjects were introduced to -12° HDT, to the MRI, and to 
the Vittamed non-invasive ICP measurement to ensure eligibility and full understanding of 
the study intervention. Inclusion criteria included male subjects age 30-55 with 
cardiovascular, exercise capacity and mental health approximately matching the astronaut 
corps. Exclusion criteria included smoking, drug or alcohol abuse, migraine and existing 
ophthalmic conditions. 
 
8.2.3 Materials and Methods 
Intraocular and Intracranial Pressure Measurements 
IOP was measured with an Icare Pro tonometer (Icare, Helsinki, Finland) at baseline 
in the seated position, and after 1.5 h, 6.5 h and 22.5 h HDT. In addition, IOP was measured 
during exposure to 3% CO2 (27 h HDT). IOP was measured 3 times in each eye in a 
randomized order. ICP was measured with the Vittamed non-invasive ICP meter (Vittamed, 
Kaunas, Lithuania) at seated baseline and after 3 h, 7 h and 22 h HDT. ICP was measured 1-2 
times at each measurement time point.  
 
 Statistical Analysis 
ANOVA and linear mixed effect models were created with time and atmosphere as 
main effects, allowing for a time-atmosphere interaction, and subject ID as a random effect. 
For IOP, side was included as an additional term to determine the effect of lateralization. 
The level for statistical significance was set to α = 0.05 and β was set to 0.2. When main 
effects were found to be statistically significant, Bonferroni post-hoc analyses were used to 
for further comparison. Statistical analyses were carried out with IBM SPSS Statistics Version 
20 (IBM, Armonk, NY). 
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8.2.4 Results 
Intraocular Pressure 
IOP was found to have a significant main effect of time (F(4,368) = 37.8, p < 0.001), 
atmosphere (F(1,368) = 5.03, p = 0.026) and side (F(1,368) = 10.6, p = 0.001), however, with 
no significant interactions. In both atmospheric conditions, IOP increased from seated 
baseline during 3 h, 7 h and 22 h HDT exposure (Figure 16). After 27 h HDT with ambient air, 
the addition of short exposure to 3% CO2 decreased IOP back to baseline values (p = 0.03).  
 
 
Figure 16: Intraocular pressure (IOP) at seated baseline and at various time points of exposure to -
12° head-down tilt (HDT) with ambient air (solid line) or 0.5% CO2 (dotted line). IOP was also 
measured after 27 h HDT during 3% CO2 exposure. * p < 0.05 
 
 
Intracranial Pressure†† 
ICP was found to have a significant main effect of atmosphere (F(1,69) = 5.2, p = 
0.025), but not time (F(3,69) = 1.3, p = 0.29), with no significant interaction term (F(3,69) = 
0.6, p = 0.6) (Figure 17). 
                                                     
 
 
†† Intracranial pressure results from the SpaceCOT Study have been submitted for publication (paper #6, 
section 11.1) 
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Figure 17: Intracranial pressure (ICP) at seated baseline and after 3 h, 7 h and 22 h head-down tilt 
(HDT) with ambient air (solid line) or 0.5% CO2 (dotted line) 
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8.3 The SETI Study: Studying the Effects of Tilt with Lower Body Negative Pressure 
on Intraocular Pressure 
8.3.1  Study Design  
The third study, the SETI study, was designed to further elucidate the effects of a 
stronger level of LBNP (-40 mmHg) for shorter durations with an extended range of tilt 
angles on IOP. The experimental protocol (Figure 18) consisted of 12 randomized conditions: 
+12°, 0°, -6°, -12°, -18°, -24° tilt, and +12°, 0°, -6°, -12°, -18°, -24° tilt with -40 mmHg LBNP. 
Subjects remained in the 0° position for 30 min prior to the first condition. Then, each 
randomized tilt angle (with or without LBNP) was maintained for 5 min followed by a 10 min 
recovery period in the supine position before proceeding to the next condition. After the 6th 
condition, the subject was removed from the tilt table/LBNP chamber for a urination break 
and to consume 100 ml of water. The experiment then resumed with the last 6 randomized 
conditions. 
 
 
 
Figure 18: The SETI Study consisted of 6 tilt angles with and without -40 mmHg lower body negative 
pressure (LBNP) for a total of 12 randomized conditions. Each tilt condition was maintained for 5 min 
followed by 10 min in the 0° position before proceeding to the next condition.  
 
The experiment was conducted on a custom-built automatic tilt table with an 
integrated LBNP chamber (shown in the Appendix, Figure A 3). The LBNP chamber was 
sealed at the iliac crest for each subject and air conditioning was maintained inside the LBNP 
chamber during all conditions.  
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8.3.2  Subjects 
Sixteen healthy subjects (8 male, 8 female, mean ± SD age: 27 ± 4 y, height: 174 ± 10 
cm and weight: 69 ± 13 kg) were enrolled in the SETI study. All subjects underwent a basic 
medical examination prior to inclusion in the study which included an oral medical history 
interview, resting electrocardiogram, exercise test for endurance capacity and a standing 
test for orthostatic intolerance assessment. Inclusion criteria consisted of subjects between 
the ages of 20-45 yrs, BMI of 20-26 kg/m2 and a height of 158-190 cm. Subject exclusion 
criteria included smoking, current prescription medication use, history of cardiovascular 
diseases and severe orthostatic intolerance. 
 
8.3.3  Materials and Methods 
Intraocular Pressure Measurements 
IOP was measured with an Icare Pro tonometer (Icare, Helsinki, Finland). 
Measurements were taken between the 9-10th min at supine baseline between each 
condition, and between the 4-5th min of tilt. Two-three IOP measurements were taken in 
each eye at every time point in a randomized order.  
 
Statistical Analysis 
All statistical analyses were carried out with R version 3.1.2 64-bit (www.r-
project.org) in the R-studio environment (version 0.98.1049). ANOVA and linear mixed 
effect models were constructed with time (baseline and HDT), condition and side as main 
effects and subject as a random effect. In addition, the model allowed for a time-condition 
interaction. Bonferroni post-hoc analyses were implemented for further comparison when 
main effects were found to be significant. The level for statistical significance was set to α = 
0.05 and β was set to 0.2. 
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8.3.4 Results‡‡ 
Intraocular Pressure 
IOP had significant main effects of both time (F(1,767) = 65.5, p < 0.001) and 
condition (F(11,767) = 17.9, p < 0.001), with a significant time-condition interaction 
(F(11,767) = 21.7, p < 0.001). In addition, there was a trend towards significance for eye 
lateralization (F(1,767) = 5.1, p = 0.05). Post-hoc analysis revealed that IOP increased from 
an average baseline of 14.7 ± 0.1 mmHg to 15.7 ± 0.4 mmHg during -12° HDT (p = 0.02), 16.5 
± 0.3 mmHg during -18° HDT (p < 0.001) and 18.4 ± 0.4 mmHg during -24° HDT (p < 0.001) 
(Figure 19). The use of -40 mmHg LBNP during HDT successfully counteracted these 
increases in -12° and -18° HDT, with no significant increase from baseline during these 
conditions (p = 0.99 and p = 0.73, respectively). LBNP also lowered the IOP to 16 ± 0.3 
mmHg during -24° HDT, however, IOP was still increased from supine baseline (p < 0.001). 
 
Figure 19: Intraocular Pressure at supine baseline (BDC) and during various degrees of whole body 
tilt with and without lower body negative pressure (LBNP); * p < 0.05, *** p < 0.001  
                                                     
 
 
‡‡ Intraocular pressure results from the SETI study have been published (84). 
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9 Discussion 
The recently discovered structural and functional ophthalmic changes that occur 
during and after long-duration spaceflight represent a maladaptive physiological response 
to extended microgravity exposure. While the exact etiology of these ocular changes is 
currently unknown, cephalad fluid shifting due to the loss of physiologic hydrostatic 
pressure gradients in microgravity is hypothesized to be a major underlying factor. Here, 
three studies were implemented to further understand the effects of cephalad fluid shifting 
through HDT on cerebral and ocular anatomy and physiology as well as the additive or 
attenuating effects of increased ambient CO2 and LBNP, respectively. Notably, two of the 
presented studies represent the first experiments to investigate the combined effects of 
HDT and increased ambient CO2, hypothesized to be a more realistic analog to the unique 
ISS environment. Furthermore, the use of LBNP during HDT was tested as a potential 
countermeasure to cephalad fluid shifting at low and strong levels for short (5 min) and 
moderate durations (5 h) to test for feasibility of use and efficacy. Overall, the presented 
experiments and subsequent findings set a foundation for future studies investigating 
cerebral and ocular anatomy and physiology in a ground-based spaceflight analog to build 
upon and have determined key factors that may help elucidate the causative mechanisms of 
ocular changes in astronauts, namely the roles of the translaminar pressure difference, 
cerebral hemodynamics and cerebral venous congestion. 
 
9.1 Cerebral Hemodynamics 
Central to the hypothesized underlying mechanisms of ocular changes in astronauts 
is a disruption in the cerebral hemodynamic system, likely due to decreased cerebral venous 
outflow and increased cerebral venous pressure (Figure 3). PC-MRI was utilized to study the 
effects of cephalad fluid shifting through various degrees of HDT as well as increased 
ambient CO2 on the CSA, blood flow velocity and blood volume flow in the major vessels of 
the neck. The results demonstrated that HDT induced a decrease in arterial and venous 
blood flow and velocity as well as a large increase in IJV CSA. Notably, breathing 1% CO2 
during HDT increased blood flow on both the arterial and venous side compared to HDT 
with ambient atmosphere, bringing blood flow closer to supine baseline values.  
CBF velocity has been investigated previously in both HDT and microgravity, 
however, with inconsistent results. Previously, CBF velocity through the middle cerebral 
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artery (MCA) was found to increase when going from the upright seated position to the 
supine position, however no further change was detected going from the supine to the -15° 
HDT position in healthy subjects (10). In another study, during 24 h exposure to -6° HDT, CBF 
velocity through the MCA was found to increase compared to seated baseline values, 
peaking at 3 h HDT and remaining increased during the full 24 h (60). During 48 h exposure 
to -10° HDT, MCA CBF velocity also increased immediately, but slowly decreased over 48 h 
HDT, back to seated baseline values (38). However, in another study where subjects 
underwent 21 d exposure to -6° HDT, MCA CBF velocity decreased immediately and 
remained below baseline values, although baseline posture was not reported (115). During 
spaceflight, no change in MCA CBF velocity was detected after 10 h or 1-2 weeks of 
microgravity exposure (12, 54). The discrepancy between the decreased arterial blood flow 
velocity found in the enVIIP study and the aforementioned HDT and spaceflight studies may 
be due to differences in methodologies (TCD vs. PC-MRI), comparative baseline posture or 
vessels measured. Notably, the ICA is known to have a lower blood flow velocity than the 
MCA (70), and changes in blood flow and velocity induced by environmental factors have 
been shown to affect vessels differently (130). 
Furthermore, both total arterial inflow and jugular venous outflow were found to 
decrease during HDT in a non-linear manner. Regulation of CBF is vital for brain homeostasis 
and is controlled by a number of interrelated physiological factors including cerebral 
autoregulation, cerebral perfusion pressure (CPP; MAP - ICP), metabolic demands, partial 
pressures of O2 and CO2, and the autonomic nervous system (131). Due to impeded 
intracranial venous outflow during HDT, post-capillary pressure may have been increased, 
affecting the CPP gradient and thus, resulting in the demonstrated decrease in arterial blood 
flow. However, between -12° and -18° HDT, blood flow did not decrease further, but rather 
achieved steady-state or even increased slightly. Potential explanations considered include 
an accumulation of CBF-regulating metabolites including K+ and CO2 or an increased cerebral 
metabolic rate of oxygen consumption due to anxiety; however, no change in pulse rate was 
detected. Further, it is possible that shifting of abdominal contents during HDT affected 
minute ventilation, thus raising the PaCO2 and increasing CBF. However, no changes in 
minute ventilation were detected during any HDT angle and ETCO2 was unchanged between 
-12° and -18° HDT. Interestingly, cerebral hemodynamic impairment, hypo-perfusion and 
altered CBF regulation have been proposed as etiological factors in mild cognitive 
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impairment (85). In healthy controls, an acute lowering of CBF by 30% is associated with 
mild symptoms of cerebral hypo-perfusion, and lowering CBF by 50-60% can induce mental 
confusion (113). Further investigation of CBF and cognitive abilities during longer-duration 
exposure to HDT are warranted. Currently, astronauts do not appear to have significant 
cognitive issues during 6-month missions in space as they are still able to perform their tasks 
nominally. However, when discussing longer exploration missions (2+ years), it is unknown 
how the cerebral vascular system will be affected and potential cognitive issues thereafter. 
Compared to the cerebral arterial system, fewer studies have been devoted to the 
physiological assessment of the cerebral venous system, which is known to have asymmetric 
anatomy along with significant individual and hemispheric variations (4, 104). However, the 
cerebrovascular system is central to the maintenance of cerebral perfusion and ICP. 
Progressive increases in IJV CSA with HDT found in the enVIIP study are presumably due to 
increased jugular venous pressure from the newly established hydrostatic pressure gradient 
and demonstrate the compliance of the venous system. Increased IJV CSA has been 
previously described during -6° HDT exposure and was found to remain increased after 42 
days of HDT (8). Increased IJV CSA has also been found in microgravity, remaining distended 
even after 5 months of spaceflight (8, 47); however, this could also be due to tissue weight 
unloading in the neck. In a study by Arbeille et al. (2015), increases in both IJV and portal 
vein volumes were found after 15 days of microgravity exposure (178% and 36%, 
respectively) and remained increased after ~5 months in space, indicating blood pooling in 
the cephalad and, to a lesser extent, pelvic regions during spaceflight (9).  
Jugular venous outflow followed a similar pattern as arterial inflow during HDT. 
Extra-jugular pathways (i.e., the vertebral veins) were not measured in the current study; 
however, the IJVs are known to be the dominant outflow pathway in the supine and 
presumably HDT positions (80). The IJVs accounted for ~70% of the arterial inflow at supine 
baseline and during HDT, in-line with previously reported values (5, 13, 114). Interestingly, 
the proportion of cerebral venous outflow through the IJVs increased to about 85% during -
12° HDT with the addition of 1% CO2, suggesting a relative reduction in return through the 
vertebral veins. Notably, increased ambient CO2 during HDT counteracted the HDT-induced 
decrease in cerebral arterial inflow and venous outflow, bringing blood volume flow close to 
supine baseline levels. Hypercapnia and increased PaCO2 is known to have potent 
vasodilatory effects, increasing CBF. However, the combined effects of HDT and CO2 have 
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not been investigated. Paradoxically, a low-level hypercapnic environment appears to be 
beneficial instead of detrimental to the blood flow rates, tending to return them back to 
baseline values.  
 
9.2 Intraocular and Intracranial Pressure 
The aforementioned disruptions to the cerebral hemodynamic system are 
hypothesized to be the main underlying factor influencing both IOP and ICP. In the 
presented experiments, IOP and ICP increased with HDT, although in a divergent way. IOP 
was found to increase with steeper HDT angles immediately (the SETI study) and remained 
increased after several hours of HDT (the enVIIP study). However, a slow decrease in IOP 
was seen over 22 h HDT exposure (the SpaceCOT study). ICP on the other hand was only 
found to increase significantly with steeper HDT (-18° HDT). Thus, it is important to take 
both ICP and IOP into consideration when discussing pathologies related to the ONH and 
subsequent vision changes as disruptions to the homeostatic TLPD can have significant 
effects on ocular structures and vision.  
 Previous studies have demonstrated that IOP increases immediately upon exposure 
to both real (7, 76) and simulated microgravity (75), consistent with the presented results of 
the SETI and enVIIP study. This immediate increase in IOP is hypothesized to be due to 
increased cerebral venous pressure and vortex venous pressure resulting in engorgement of 
the choroid; this would then increase intraocular volume resulting in an immediate spike in 
IOP. Increased choroid thickness/area during HDT (107) as well as short-duration exposure 
to microgravity (7) have been previously demonstrated. However, in the enVIIP study, no 
change in sub-foveal choroid thickness was found during HDT. This may be due to 
instrument and body position limitations in the enVIIP study: the head had to be placed on a 
horizontal platform in front of the camera and therefore, the head was not in line with the 
HDT angle possibly alleviating choroidal congestion. In addition to choroidal engorgement, 
increased episcleral venous pressure and therefore increased aqueous humor outflow 
resistance may also play a role in the sustained increases in IOP seen in the first days of HDT 
(79) and spaceflight (32). Interestingly, within one week of both HDT (24) and microgravity 
exposure (32, 106), IOP appears to normalize back to baseline values. IOP has also been 
found to decrease below baseline values post-HDT bed rest (79) as well as post-spaceflight 
(31). As a compensatory decrease in aqueous humor volume in response to increased 
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choroidal volume is hypothesized to occur in space, re-introduction to the hydrostatic 
pressure gradients associated with the upright position on Earth would then decrease 
choroid volume and result in a drop in IOP below baseline until aqueous humor volume 
returned to normal.  
According to the Davson equation (25; Equation 1-1), ICP is highly dependent on the 
cerebral venous pressure. As the venous system is a fully communicating fluid system and 
thus subject to hydrostatic pressure gradients (53), ICP is also hypothesized to increase with 
HDT. Several studies have demonstrated the postural variations of ICP, increasing about 11-
14 mmHg when going from the upright to the supine position (34, 96, 99). During 5 min 
exposure to -10° and -20° HDT, Petersen et al. (2016) found ICP to increase 4.9 and 9.6 
mmHg, respectively, from supine baseline. Eklund et al. (2016) found ICP to increase 4 
mmHg after 3 min exposure to -9° HDT (34). Other non-invasive methodologies 
implemented during HDT including tympanic membrane displacement (91) and cranial 
ultrasound pulse amplitude techniques (75) suggest increased ICP, however, absolute ICP 
values cannot currently be derived from these techniques. Increased ICP can also cause 
cortical bridging veins that transverse through the SAS to collapse. These veins thus act as 
starling resistors, causing increased cerebral venous outflow resistance when CSF pressure 
exceeds cerebral venous pressure (17). 
In any fully communicating fluid system, the pressure at a specific point can be 
determined by its distance from the hydrostatic indifference point, the point in a fluid 
system where pressure is unaffected by body position (86). Thus, ICP changes with body 
position can be predicted by hydrostatic pressures using the following equation: 
 
 
 
ICP(α) = ICP(0°) - (p x g x L) x sin(α) Equation 3-1 
where α is the HDT angle, p = density of the liquid, g = acceleration due to gravity, and L is 
the distance from the reference point. Based on the findings from invasive measures by 
Petersen et al. (2016), the distance from the external auditory meatus to the reference 
point (L), which likely corresponds to the hydrostatic indifference point of the venous 
system, is about 37 cm (96). Thus, the predicted increase in ICP based on hydrostatic 
pressure gradients alone with -6°, -12° and -18° HDT is 2.9, 5.8 and 8.7 mmHg, respectively. 
In healthy subjects, no changes in ICP were detected at -6° or -12° HDT in either the enVIIP 
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or SpaceCOT studies, however, a ~5 mmHg increase in ICP was found after 3.5 h of -18° HDT 
in the enVIIP study. This discrepancy may partially be accounted for by the non-invasive 
technique implemented. The TCD-based non-invasive ICP measurement utilized in the 
enVIIP and SpaceCOT studies has been previously found to have correlation good with 
invasive measures with a mean difference of 4.5 mmHg between paired measurements (19). 
It is therefore possible that ICP was slightly increased during -6° and -12° HDT, however, was 
not detected by the non-invasive measurements. Interestingly, the calculation of ICP based 
on Equation 3-1 is only applicable to HDT. In head-up tilt positions, the IJVs collapse at the 
level of the jugular venous valves - approximately 11 cm below the external auditory meatus 
(99). This results in the creation of a separate hydrostatic column, preventing very negative 
ICP values in the upright position. In microgravity, however, all hydrostatic pressure 
gradients are eliminated, fluids shift headward with notable facial edema (67) and 
decreased leg volume (89) and the IJVs remain continuously open. In a primate, ICP was 
measured directly during a 9 d spaceflight on-board a Russian Cosmos-2229 biosatellite; ICP 
was found to increase 25-30% immediately compared to seated baseline and decrease over 
the second half of the mission close to baseline values, although still slightly elevated (118). 
More recently, ICP was measured in parabolic flight, allowing sequences of 20 s of 
microgravity exposure followed by hyper-gravity; ICP was found to be increased during 
microgravity exposure compared to seated baseline levels (13 vs 4 mmHg, respectively), 
although, was decreased from supine baseline (15 mmHg; 58). 
Taken together, postural changes on Earth result in a much larger change in ICP than 
IOP when going from the supine to the upright positions - about 12-13 mmHg (96, 99) vs. 2-
3 mmHg (7, 75), respectively. Thus, a large TLPD exists 2/3rds of the day whilst in the upright 
position with a decreased TLPD for the remaining 1/3rd of the day while in the supine 
position, although still positive. As there is no upright position in microgravity and ICP is 
hypothesized to remain slightly elevated, a sustained decreased TLPD is hypothesized to 
occur 24 h/day, which may be similar to remaining in the HDT position continuously. 
Changes in the TLPD influence strains on the ONH, notably within the retrolaminar ON, 
which can initiate cellular responses (16) and tissue remodeling effects in the ONH (30). 
However, the true translaminar pressure gradient is not just equal to the difference in IOP 
and ICP but rather biomechanical and material properties of the various ocular tissues must 
be taken into account. A modeling study by Feola et al. (2016) found that in addition to IOP 
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and ICP, material properties of the peripapillary sclera, annular ring, lamina cribrosa, ON and 
pia matter also have strong influences on strains in the ONH (35). Notably, lamina cribrosa 
stiffness and thickness can affect the translaminar pressure gradient, with a thicker lamina 
cribrosa spreading the gradient out over a greater distance and reducing shear stress (90). 
Interestingly, with increasing age, lamina cribrosa thickness increases due to increased 
collagen (68), however, compliance decreases thereby potentially increasing susceptibility 
to permanent deformation (2). Thus, anatomical differences may be a factor in the variance 
in severity of ocular changes observed in astronauts presenting with the VIIP syndrome, as 
any changes in ICP or IOP will result in an amplified translaminar pressure gradient across a 
thinner lamina cribrosa. 
 
9.3 Intracranial and Orbital Cerebrospinal Fluid 
In addition to the venous system, CSF is also subject to hydrostatic pressure 
gradients. Therefore, when going from the upright to the supine to the HDT position, a 
portion of CSF is displaced from the spinal to the intracranial SAS. This increase in 
intracranial CSF volume was demonstrated in the enVIIP study. In a longer duration study, 
Roberts et al. (2015) found no change in CSF, WM or GM volumes after 42-60 d of -6° HDT 
bed rest (102). Interestingly, Alperin et al. (2013) found increased intracranial CSF and GM 
volume in IIH patients compared to age- and weight-matched controls, potentially due to 
impaired CSF homeostasis and reduced cerebral drainage through the IJVs (6). Notably, the 
HDT-induced increase in CSF volume in the enVIIP study was mitigated with the use of LBNP 
in the -12° HDT position, back to baseline values. This was likely due to LBNP redistributing 
venous blood volume to the lower limbs during HDT, indirectly impacting intracranial CSF 
volume.  
The intracranial CSF-filled SAS also extends around the ON. This is a unique point in 
the cephalad CSF circulation as it lies outside of the rigid cranium (Figure 2), and therefore 
distends when ICP is elevated, particularly in the retrobulbar ONS (21, 48, 66). Geeraerts et 
al. (2008) found that 3 mm behind the eye globe, mean MRI-derived ONSD was higher in 
traumatic brain injury patients with an ICP > 20 mmHg (6.31 ± 0.5 mm) compared to 
traumatic brain injury patients with ICP ≤ 20 mmHg (5.72 ± 0.71 mm) as well as healthy 
controls (5.08 ± 0.52 mm; 36). Interestingly, Kramer et al. (2012) scanned 27 astronauts 
(mean age ± SD: 48 ± 4.5 yrs) post-spaceflight and performed repeated imaging of 8 
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astronauts after an additional spaceflight (69). Mean ONSD was found to be 6.2 ± 1.1 mm, 
greater than reported values for healthy controls, alluding to increased ICP. However, all 
data were obtained post-flight, thus no baseline or control data are available for 
comparison. Although non-invasive measures of ICP in the enVIIP study only found 
increased ICP during -18° HDT, the progressive increases in ONSD with HDT suggests 
increased ICP during all HDT angles. However, pressure within the ON SAS may not 
necessarily reflect global ICP. The ONS SAS is extremely narrow with numerous trabeculae 
and septae restricting free flow of CSF (64). Thus, the ON SAS may form a separate 
compartment in some cases. This has been demonstrated in patients with asymmetric 
papilledema, showing altered CSF biomarkers in ONS vs. spinal CSF (61).  
Interestingly, in the enVIIP study, the average ONSD 3 mm behind the eye globe at 
supine baseline was 5.96 ± 0.07 mm, slightly higher than mean reported values for healthy 
controls (15, 40). This may be due to the fact that a straight ahead eye gaze was maintained 
and strictly controlled for during ocular scanning in the present study, which is rarely 
mentioned in other protocols. This is important as Weigel et al. (2006) demonstrated that 
ONSD measurements are sensitive to eye gaze positioning, with a straight gaze resulting in a 
larger ONSD measurement than a 30° abduction gaze in the same individuals (5.7 vs. 5.4 
mm, respectively; 110). In addition, a larger range of ONSD values have been found in 
measurements made with MRI compared to ultrasound in health adults (4.7 – 7.9 mm vs. 
4.6 – 6.4 mm, respectively; (15), and comparisons between ultrasound- and MRI-derived 
ONSD measures warrant caution (41).  
 
9.4  Increased Ambient Carbon Dioxide 
As CO2 is a natural metabolic byproduct expelled through respiration, ambient CO2 
levels will rise within closed environments such as the ISS unless active mechanisms are 
implemented to scrub the atmosphere. Thus, CO2 levels are, on average, 10x higher on the 
ISS compared to terrestrial levels (0.5% vs. 0.04%, respectively), with a spacecraft maximum 
allowable concentration limit of 0.5% CO2 for 1000 d exposure (55). As a potent cerebral 
arterial vasodilator, CO2 is hypothesized to contribute the existing cephalad fluid shift 
induced-increase in ICP via further increasing intracranial blood volume (Figure 3; 52). The 
combination of cephalad fluid shifting and exposure to increased ambient CO2 is unique to 
the microgravity environment and therefore important for any ground-based simulation 
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studies to simulate. It should be noted though that exposure to a CO2-enriched atmosphere 
may not directly translate to increased CO2 uptake or increased end tidal CO2 due to 
enhanced ventilatory dissipation of CO2. For example, in the enVIIP study, exposure to -12° 
HDT with 1% CO2 was found to increase end tidal CO2 by 0.47% compared to -12° HDT with 
ambient air. In another study, 3% CO2 exposure was found to increase end tidal CO2 by 0.6% 
in the supine position (51). However, on the ISS, end tidal CO2 has been reported to be 
increased from preflight baseline (50). Interestingly, while the removal of gravity in space 
results in more uniform ventilation and perfusion in the lung, gas exchange is unchanged 
(97). In HDT, the cardiopulmonary effects are similar to that of the supine position (98). 
Cerebral CO2 reactivity was found to remain intact in the enVIIP study as exposure to 
-12° HDT with 1% CO2 increased both cerebral arterial inflow and jugular venous outflow 
compared to -12° HDT with ambient air. Tymko et al. (2015) also found no change in 
cerebrovascular reactivity with extreme -45° and -90° tilt (122). Interestingly, Zuj et al. 
(2012) found impaired cerebrovascular CO2 reactivity and autoregulation in the MCA after 
long-duration spaceflight, possibly due to chronic exposure to increased ambient CO2 on the 
ISS (133). In addition, headache incidence on the ISS has been found to be correlated with 
CO2 levels and suggests increased susceptibility at lower ambient CO2 levels (71). Individual 
CO2 sensitivity and retention may play a role in why some astronauts appear to be more 
affected by CO2 than others; however, this may also be due to individual exposure to large 
fluctuations in CO2. In the presented studies, elevated ambient CO2 had little or no additive 
effect on IOP or ICP during short- (the enVIIP study) or moderate-duration (the SpaceCOT 
study) HDT. Further, no additional changes were detected in intracranial volumes, ONSD, 
sub-foveal choroidal thickness or cardiovascular parameters with the addition of low level 
CO2 during HDT. Thus, increased ambient CO2 may not play a large role in the development 
of ocular abnormalities during spaceflight as originally hypothesized. However, further 
studies are warranted to determine the effects of long-term exposure to elevated ambient 
CO2 on cerebral hemodynamics as well as the interplay with additional environmental 
factors on the ISS.  
 
9.5  Lower Body Negative Pressure 
While increased ambient CO2 was hypothesized to be an exacerbating factor to HDT-
induced changes in cerebral and ocular physiology, LBNP was tested as a potential 
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countermeasure to HDT-induced cephalad fluid shifting and downstream ocular effects. 
Implementation of -15 to -30 mmHg LBNP in the supine position elicits the same 
physiological responses as the loss of ~1 L of centrally available blood volume (101), and is 
frequently used to study the effects of hemorrhage and orthostatic tolerance (43). In 
addition, LBNP induces a decrease in CBF velocity as well as CVP (56) and an increase in MAP 
(56, 73, 121). 
In the SETI study, exposure to -40 mmHg LBNP during various degrees of HDT was 
demonstrated to have immediate effects on IOP, attenuating HDT-induced increases in IOP 
up to -18° HDT. This demonstrates the ability of LBNP to directly affect the eye, likely due to 
LBNP redistributing venous blood to the lower limbs, reducing CVP and cerebral venous 
pressure and thus reducing aqueous humor outflow resistance and choroidal blood volume. 
However, immediately upon cessation of LBNP and HDT, IOP returned to baseline values. 
Thus, LBNP-induced changes in IOP may not be sustainable. For LBNP to be a feasible 
countermeasure against microgravity-induced headward fluid shifting and the cascade of 
cerebral and ocular effects, it will likely need to be applied for longer durations (i.e., 
overnight) to act as a simulation of normal diurnal posture changes that occur during daily 
life on Earth, specifically by simulating the upright position. However, implementation of 
strong LBNP (-40 to -50 mmHg) can result in syncope in some subjects after just 5-10 min 
exposure (101, 121). Therefore, in order to determine the feasibility of using LBNP over 
longer durations, low level (-20 mmHg) LBNP was implemented during -12° HDT for a total 
of 5 h. At this LBNP level, subjects tolerated the countermeasure with reasonable comfort. 
However, IOP remained increased from the supine baseline after 3.5 h and no change in ICP 
was detected. Macias et al. (2015) found that 10-min exposure to low-level (-25 mmHg) 
LBNP during -15° HDT returned IOP to supine baseline levels and reduced transcranial 
ultrasound pulse amplitude, alluding to decreased ICP although no absolute value is 
available from the implemented technique (75). Although low-level LBNP during HDT 
immediately decreased IOP back to supine baseline levels in that study, the changes may 
not be sustainable over longer durations as evidenced by the results of the enVIIP study. 
While low-level LBNP had minimal effects on IOP and ICP over multiple hours, a 
notable reduction in orbital and intracranial CSF volume was found compared to -12° HDT 
alone. This novel finding is likely due to an LBNP-induced decrease in CVP and enhanced 
cerebral drainage. Although CVP was not measured in the present study, exposure to 5 min 
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LBNP at -15, -30 and -45 mmHg has been shown to decrease CVP by 4.5, 6.3 and 7.7 mmHg, 
respectively (56). The ability of LBNP, an approach primarily targeting venous blood 
distribution, to directly influence orbital as well as intracranial CSF volumes indicates great 
potential in this approach for future countermeasures against increased periorbital CSF-
pressure and resulting ocular changes. However, a balance between comfort and 
effectiveness must be determined for feasibility of implementation over multiple hours.  
 
9.6  Idiopathic Intracranial Hypertension and the VIIP Syndrome 
Although there are several similarities between the structural ophthalmic changes 
seen in both IIH patients and astronauts presenting with the VIIP syndrome, there are also 
marked differences between the two. IIH primarily affects obese women of child bearing 
age (125), and is frequently accompanied by pulse synchronous tinnitus and diplopia, not 
found in astronauts. The VIIP syndrome has been predominantly found in healthy male 
astronauts with a mesomorphic build, however, this may be due to affect a greater 
proportion of males in space over the past 15 years than females. Interestingly, only 10% of 
IIH patients presenting with papilledema also have choroidal folds, the presence of which is 
normally associated with high ICP (108). In contrast, about 60% of astronauts with 
papilledema also present with choroidal folds (77) that are strongly unilateral and 
predominately present in the right eye, perhaps alluding to global or local (periorbital) 
increased CSF pressure in microgravity. This may, however, be due to the relatively low 
sample number compared to clinical studies on Earth or due to increased susceptibility to 
mechanical folding due to choroidal expansion in microgravity (77).  
Interestingly, the ocular changes in astronauts appear to affect the right eye more 
than the left (78). On the contrary, asymmetric papilledema in patients with IIH is fairly 
uncommon, occurring in less than 4% of patients (20). Bidot et al. (2015) found that in IIH 
patients with asymmetric papilledema, the eye with the lower grade edema also had a 
smaller bony optic canal and hypothesized that a smaller bony optic canal is protective by 
preventing CSF pressure to be fully transmitted along the ON (20). However, this does not 
explain why the right side is consistently more affected in microgravity as it is highly unlikely 
that all astronauts display the same anatomical asymmetry. Although this hypothesis 
warrants further investigation, it would be interesting analyze bony optic canal size in VIIP-
affected and non-affected astronauts in the future. Lateral variations were found in several 
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instances in the presented studies. First, all presented studies showed at least a trend 
towards significance for an effect of lateralization on IOP. While this may also be due to the 
relatively small sample sizes, asymmetric IOP could have notable effects on the TLPD, 
especially when coupled with potential asymmetric bony optic canals and periorbital CSF 
pressure. Interestingly, the likelihood of developing primary open-angle glaucoma has been 
found to increase with increasing IOP asymmetry as well (129). In addition, about 75% of 
subjects in the enVIIP study had a higher flow rate through the right IJV, in-line to previously 
reported values in healthy subjects (112). The cerebral venous system is known to have 
inter-individual variations and significant lateralization throughout the system (4, 33, 116). 
However, the significance and clinical implications of physiological bilateral variations has 
yet to be determined and warrants future investigation.  
Taken together, although several similarities can be drawn between IIH and the 
ocular changes experienced by astronauts, the etiology of the VIIP syndrome appears to be 
unique to the microgravity environment. However, it is notable that both syndromes include 
signs consistent with a lack of ICP reductions normally experienced in the upright position 
due to either an abnormally increased ICP in the upright position in IIH or a lack of upright 
position all together in space.  
 
9.7  Limitations 
There are several limitations to consider when interpreting the results of the 
presented studies. First, the studies exhibited relatively small sample sizes which could have 
prevented some results from reaching statistical significance, and thus, results were 
interpreted with caution. Second, one of the main limitations of HDT bed rest as an analog is 
that unlike in microgravity where all gravitational forces are eliminated, the Gx (dorsal-
ventral) gravitational gradient is maintained during HDT which may result in a different 
cardiopulmonary response compared to microgravity. In addition, a small headward 
gradient is created approximating 0.1 Gz [= sin(-6°)]. While this foot-to-head gradient is 
meant to induce a headward fluid shift as experienced in microgravity, it is of importance to 
note that the physiological means of the fluid shift are very different in nature as no 
hydrostatic pressure gradients exist in space. Third, the HDT with increased ambient CO2 
studies did not use computer controlled systems to continually alter individual PaCO2 to a 
controlled level. Rather, subjects were exposed to a constantly increased ambient CO2 
58 
 
breathing mixture as this is more representative of the spaceflight environment. However, it 
should be noted that individual ventilatory responses to CO2 can be variable. Thus, some 
subjects may have had a higher PaCO2 and stronger physiological reactions thereof. It 
should also be noted that while the presented work focused on the hypothesis that 
impaired cerebral hemodynamics and cephalad fluid shifting are the main hypothesized 
contributor to the VIIP syndrome, other contributing factors have been proposed including a 
high sodium diet, resistive exercise (3), enzymatic polymorphisms in the 1-C metabolism 
cycle (134) and anatomical shifting in microgravity (128). 
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10 Conclusion and Future Perspectives 
Overall, the presented studies investigated cerebral and ocular physiology during 
various degrees of HDT with and without increased ambient CO2 to further understand the 
effects of cephalad fluid shifting and the possible etiology of ocular changes in astronauts. 
The overarching hypothesis depicted in Figure 3 was that alterations in cerebral 
hemodynamics, namely increased cerebral venous pressure, can induce a cascade of 
cerebral and ocular effects that may ultimately result in the vision and structural ophthalmic 
changes seen in astronauts. The results indicate that HDT leads to cerebral venous 
congestion demonstrated by the large increase in IJV CSA and decreased jugular venous 
outflow flow from PC-MRI derived measures. Furthermore, HDT-induced increases in 
intracranial CSF volume and ONSD are consistent with decreased CSF absorption due to 
elevated cerebral venous pressure. In addition, an important downstream consequence of 
HDT-induced alterations in cerebral hemodynamics is a change in the translaminar pressure 
gradient (Figure 3). Interestingly, a small, positive intraocular-intracranial pressure 
difference (IOP > ICP) is maintained during both acute and overnight HDT exposure. This is in 
contrary to the hypothesized shift to a negative intraocular-intracranial pressure difference 
that can result in significant structural and functional ophthalmic changes, for example in 
patients with IIH. However, even though a positive intraocular-intracranial pressure 
difference is maintained, it is smaller than the nominal pressure difference that occurs in 
the upright position on Earth due to a very low or even negative intracranial pressure in this 
position. Thus, there is a constantly elevated pressure on the back of the eye during HDT 
and possibly also in space. The lack of periorbital pressure alleviation due to disruptions in 
cerebral hemodynamics may play a role in the ultimate structural and functional ophthalmic 
changes that develop in association with the VIIP syndrome. 
In addition to cephalad fluid shifting due to the loss of hydrostatic pressure gradients 
in space, exposure to increased ambient CO2 on the ISS was hypothesized to be an 
exacerbating factor to an existing microgravity-induces increase in ICP (Figure 3). However, 
in the presented studies, increased ambient CO2 in combination with HDT had little additive 
effect on ICP or IOP during short- (3 h) or moderate-duration (29 h) exposure. Further, no 
additional effects were seen on ONSD or intracranial CSF volume during HDT with increased 
ambient CO2. However, exposure to elevated ambient CO2 was found to have notable 
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effects on cerebral hemodynamics including increasing cerebral arterial blood flow and 
venous outflow compared to HDT alone. The long-term implications for the CO2-induced 
changes in cerebral hemodynamics in combination with real or simulated microgravity are 
unknown and warrant further investigation to determine potential implications for the VIIP 
syndrome. 
Finding a way to mitigate vision changes in space is vital to ensure long-duration 
exploration class mission feasibility and success. Therefore, LBNP was implemented in the 
HDT position to test its ability to redistribute venous blood volume to the lower limbs as a 
potential countermeasure to cephalad fluid shifting. This approach directly targets the 
primary hypothesized causative mechanism underlying the VIIP syndrome, increased 
cerebral venous pressure. Notably, 5 h exposure to low-level LBNP (-20 mmHg) during -12° 
HDT was able to successfully attenuate the HDT-induced increase in periorbital CSF (ONSD) 
as well as intracranial CSF volume. Although -20 mmHg LBNP had additional no effect on ICP 
or IOP during HDT, exposure to -40 mmHg LBNP for short durations was able to reduce HDT-
induced increases in IOP during a range of tilt angles. Thus, LBNP is a promising technique to 
counteract cephalad fluid shifting by redistributing venous volume to the lower limbs and 
attenuate HDT-induced elevations in intracranial as well as periorbital CSF volume. 
Overall, the presented studies represent novel investigations into the cerebral and 
ocular effects of various degrees of cephalad fluid shifting through a range of HDT angles as 
well as the unique combination of HDT and increased ambient CO2 as a more realistic analog 
of the ISS. LBNP was also established as a promising countermeasure to headward fluid 
shifting and demonstrated direct effects on intracranial and orbital CSF. These studies 
contributed to the understanding of potential mechanisms involved in the development of 
ocular changes in astronauts, notably the central role of cerebral hemodynamics and 
cerebral venous congestion as well as the intraocular-intracranial pressure difference. 
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Figure A 1: Spectral domain optical coherence tomography imaging performed in the A) upright and 
B) head-down tilt positions 
 
 
  
A. B.
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Figure A 2: Custom-built MRI-compatible systems for administration of 1% CO2 and -20 mmHg lower 
body negative pressure (LBNP) during -12° head-down tilt (HDT). 
 
-12° HDT + 1% CO2
-12° HDT + -20 mmHg LBNP
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Figure A 3: SETI study setup with the automatic tilt table and integrated lower body negative 
pressure chamber 
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Table A 1: Example daily schedule for one condition of the enVIIP study 
 
Time Subject 1 
 
Subject 2 
7:00 BDC 
   7:30 OCT BS 
   8:00 Breakfast 
   8:30 ICP 
 
BDC 
9:00 Cardio Innocor 
 
OCT BS 
9:30 MRI  
Breakfast 
10:00 
 
ICP 
10:30 IOP/OCT BS/US 
 
Cardio Innocor 
11:00 Snack 
 MRI 11:30 Start HDT 
 12:00 
   
IOP/OCT BS/US 
12:30 Cardio 
 
Snack 
13:00 OCT 
  
Start HDT 
13:30 Cardio 
   14:00 Snack 
 
Cardio 
14:30 Cardio  Innocor 
 
OCT 
 15:00 OCT IOP  ICP 
 
Cardio 
15:30 Cardio 
 
Snack 
16:00 MRI  
Cardio  Innocor 
16:30 
 
OCT IOP  ICP 
17:00 BS US 
 
Cardio 
17:30 
   MRI 18:00 
   18:30 
   
BS US 
19:00 
      
BDC = baseline data collection, OCT = optical coherence tomography, BS = blood sample, ICP = 
Vittamed non-invasive intracranial pressure measurement, cardio = cardiovascular measures, 
Innocor = respiratory measures, MRI = magnetic resonance imaging, IOP = intraocular pressure, US = 
urine sample, HDT = head down tilt. 
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Table A 2: Example schedule for one campaign of the SpaceCOT Study 
 
Study Day: BDC 
 
Condition ambient atmosphere ambient atmosphere ambient atmosphere Condition 
Subject A B C Subject 
6:30 Temp, BP, HR Temp, BP, HR Temp, BP, HR 6:30 
6:45 Urine 1, BW Urine 1, BW Urine 1, BW 6:45 
7:00 BD; CO-Hb BD; CO-Hb BD; CO-Hb 7:00 
7:15       7:15 
7:30 Breakfast/Drink Breakfast/Drink Breakfast/Drink 7:30 
7:45 7:45 
8:00 Cognition fam 
supine 
    8:00 
8:15     8:15 
8:30 Plasma volume     8:30 
8:45     8:45 
9:00 CO-Hb Cognition fam 
supine 
  9:00 
9:15 Flow-mediated dilation   9:15 
9:30 Plasma volume Cognition fam supine 
9:30 
9:45 Puffy face 9:45 
10:00 
internal jugular vein + tilt 
CO-Hb   10:00 
10:15 Flow-mediated dilation   10:15 
10:30 Plasma volume 10:30 
10:45 Puffy face 10:45 
11:00 Cognition / NIRS 
internal jugular vein + tilt 
CO-Hb 11:00 
11:15 Flow-mediated dilation 11:15 
11:30 TCD / Finometer 11:30 
11:45 Puffy face 11:45 
12:00 Cflow / Fino / BGA Cognition / NIRS 
internal jugular vein + tilt 
12:00 
12:15   12:15 
12:30 IOP and OCT TCD / Finometer 12:30 
12:45 12:45 
13:00 Lunch/Drink Cflow / Fino / BGA Lunch/Drink 13:00 
13:15   13:15 
13:30 
Vittamed IOP and OCT Cognition / NIRS 
13:30 
13:45 13:45 
14:00 Lunch/Drink TCD / Finometer 14:00 
14:15 Sniffin' Sticks 14:15 
14:30 supine spiro/CO/ETCO2 
Phono / BGA Vittamed 
Cflow / Fino / BGA 14:30 
14:45   14:45 
15:00 Cerebrotech / Fino IOP and OCT 15:00 
15:15 
MRI 
Sniffin' Sticks 15:15 
15:30 supine spiro/CO/ETCO2 
Phono / BGA Vittamed 
15:30 
15:45 15:45 
16:00 Cerebrotech / Fino 16:00 
16:15 
MRI 
Sniffin' Sticks 16:15 
16:30 
Tilt Table + 
Echocardiography 
supine spiro/CO/ETCO2 
Phono / BGA 
16:30 
16:45 16:45 
17:00 Cerebrotech / Fino 17:00 
17:15 
MRI 
17:15 
17:30   
Tilt Table + 
Echocardiography 
17:30 
17:45   17:45 
18:00   18:00 
18:15   18:15 
18:30     
Tilt Table + 
Echocardiography 
18:30 
18:45     18:45 
19:00 Dinner Dinner 19:00 
19:15 19:15 
19:30     Dinner 19:30 
19:45     19:45 
20:00 PANAS + GHQ-28 
Headache questionnaire 
PANAS + GHQ-28 
Headache questionnaire 
PANAS + GHQ-28 
Headache questionnaire 
20:00 
20:15 20:15 
20:30       20:30 
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20:45       20:45 
21:00       21:00 
21:15       21:15 
21:30 Drink Drink Drink 21:30 
21:45 LOG  LOG  LOG  21:45 
22:00 
Bedtime Bedtime Bedtime 
22:00 
22:15 22:15 
22:30 22:30 
22:45 22:45 
 
Study Day: HDT 
 
Condition ambient atmosphere (start CO2 at 11:00) 
ambient atmosphere  
(start CO2 at 11:00) 
ambient atmosphere 
(start CO2 at 11:00) 
Condition 
Subject A  B C Subject 
6:30 Temp, BP, HR Temp, BP, HR Temp, BP, HR 6:30 
6:45 Urine 2, BW Urine 2, BW Urine 2, BW 6:45 
7:00 BD BD BD 7:00 
7:15       7:15 
7:30 Breakfast/Drink     7:30 
7:45     7:45 
8:00 seated spiro/CO/ETCO2 
Phono / BGA Breakfast/Drink Breakfast/Drink 
8:00 
8:15 8:15 
8:30 supine spiro/CO/ETCO2 
Phono / BGA 
    8:30 
8:45     8:45 
9:00 Puffy face seated spiro/CO/ETCO2 
Phono / BGA 
Cognition / NIRS 
seated 
9:00 
9:15   9:15 
9:30 Cognition / NIRS 
seated 
supine spiro/CO/ETCO2 
Phono / BGA 
  9:30 
9:45   9:45 
10:00   Puffy face seated spiro/CO/ETCO2 
Phono / BGA 
10:00 
10:15 Urine 3 Cognition / NIRS 
seated 
10:15 
10:30 START 0.5% CO2  
and -12° HDT 
supine spiro/CO/ETCO2 
Phono / BGA 
10:30 
10:45   10:45 
11:00 Cognition / NIRS   Puffy face 11:00 
11:15 Urine 3   11:15 
11:30 TCD / Finometer START 0.5% CO2  and -12° HDT 
  11:30 
11:45   11:45 
12:00 Cflow / Fino / BGA Cognition / NIRS   12:00 
12:15 Cerebrotech / Fino / BGA Urine 3 12:15 
12:30 IOP and OCT TCD / Finometer START 0.5% CO2  and -12° HDT 
12:30 
12:45 12:45 
13:00 Lunch/Drink Cflow / Fino / BGA Cognition / NIRS 13:00 
13:15 Cerebrotech / Fino / BGA 13:15 
13:30 
Vittamed IOP and OCT TCD / Finometer 
13:30 
13:45 13:45 
14:00 Lunch/Drink Cflow / Fino / BGA 14:00 
14:15 Sniffin' Sticks Cerebrotech / Fino / BGA 14:15 
14:30 spirometry/CO/ETCO2 
Phono / BGA Vittamed IOP and OCT 
14:30 
14:45 14:45 
15:00   Lunch/Drink 15:00 
15:15   Sniffin' Sticks 15:15 
15:30 URINE 4 + BD spirometry/CO/ETCO2 
Phono / BGA Vittamed 
15:30 
15:45 Puffy face 15:45 
16:00 Cognition / NIRS   16:00 
16:15   Sniffin' Sticks 16:15 
16:30 TCD / Finometer URINE 4 + BD spirometry/CO/ETCO2 Phono / BGA 
16:30 
16:45 Puffy face 16:45 
17:00 Cflow / Fino / BGA Cognition / NIRS   17:00 
17:15 Cerebrotech / Fino / BGA   17:15 
17:30 IOP and OCT TCD / Finometer URINE 4 + BD 17:30 
17:45 Puffy face 17:45 
18:00 
Vittamed 
Cflow / Fino / BGA Cognition / NIRS 18:00 
18:15 Cerebrotech / Fino / BGA 18:15 
18:30 IOP and OCT TCD / Finometer 18:30 
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18:45 Sniffin' Sticks 18:45 
19:00 Dinner Vittamed 
Cflow / Fino / BGA 19:00 
19:15 Cerebrotech / Fino / BGA 19:15 
19:30   IOP and OCT 19:30 
19:45   Sniffin' Sticks 19:45 
20:00 spirometry/CO/ETCO2 
Phono / BGA Dinner Vittamed 
20:00 
20:15 20:15 
20:30   spirometry/CO/ETCO2 
Phono / BGA 
20:30 
20:45 Headache questionnaire Sniffin' Sticks 20:45 
21:00     Dinner 21:00 
21:15   Headache questionnaire 21:15 
21:30 Drink Drink spirometry/CO/ETCO2 
Phono / BGA 
21:30 
21:45 LOG LOG 21:45 
22:00 
Bedtime Bedtime 
Headache questionnaire 22:00 
22:15 LOG 22:15 
22:30 Drink 22:30 
22:45 Bedtime 22:45 
 
Study Day: HDT2 
 
Condition 0.5% CO2  0.5% CO2  0.5% CO2  Condition 
Subject A B C Subject 
6:30 Temp, BP, HR Temp, BP, HR Temp, BP, HR 6:30 
6:45 Urine 4, BW Urine 4, BW Urine 4, BW 6:45 
7:00 Breakfast/Drink     7:00 
7:15 Breakfast/Drink Breakfast/Drink 7:15 
7:30 spirometry/CO/ETCO2 
Phono / BGA 
7:30 
7:45     7:45 
8:00 Cognition / NIRS     8:00 
8:15     8:15 
8:30 
Vittamed 
spirometry/CO/ETCO2 
Phono / BGA 
  8:30 
8:45   8:45 
9:00 Cognition / NIRS   9:00 
9:15 Sniffin' Sticks   9:15 
9:30 IOP and OCT Vittamed 
spirometry/CO/ETCO2 
Phono / BGA 
9:30 
9:45 9:45 
10:00 TCD / Finometer Cognition / NIRS 10:00 
10:15 Sniffin' Sticks 10:15 
10:30 Cflow / Fino / BGA IOP and OCT Vittamed 
10:30 
10:45 Cerebrotech / Fino / BGA 10:45 
11:00 URINE 4 + BD TCD / Finometer 11:00 
11:15 
MRI 
Sniffin' Sticks 11:15 
11:30 Cflow / Fino / BGA IOP and OCT 11:30 
11:45 Cerebrotech / Fino / BGA 11:45 
12:00 URINE 4 + BD TCD / Finometer 12:00 
12:15 
MRI 
12:15 
12:30 FMD, puffy face Cflow / Fino / BGA 12:30 
12:45 Cerebrotech / Fino / BGA 12:45 
13:00 Lunch/Drink URINE 4 + BD 13:00 
13:15 Urine 5 
MRI 
13:15 
13:30 START of 3% CO2  FMD, puffy face 13:30 
13:45 TCD / Cflow / Finometer 13:45 
14:00 Lunch/Drink 14:00 
14:15 IOP / ETCO2 / BGA Urine 5 14:15 
14:30 START of 3% CO2  FMD, puffy face 14:30 
14:45 Cerebrotech / Finometer TCD / Cflow / Finometer 14:45 
15:00 
MRI 
Lunch/Drink 15:00 
15:15 IOP / ETCO2 / BGA Urine 5 15:15 
15:30 START of 3% CO2  15:30 
15:45 BD Cerebrotech / Finometer 
TCD / Cflow / Finometer 
15:45 
16:00 FMD, puffy face END of 3% 
MRI 
16:00 
16:15 END of 3% CO2  IOP / ETCO2 / BGA 16:15 
16:30 Tilt Table + 16:30 
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16:45 Echocardiography BD Cerebrotech / Finometer 16:45 
17:00 FMD, puffy face END of 3% 
MRI 
17:00 
17:15 END of 3% CO2  17:15 
17:30 Urine 6, BW 
Tilt Table + 
Echocardiography 
17:30 
17:45 spirometry/CO/ETCO2 
Phono / BGA 
BD 17:45 
18:00 FMD, puffy face END of 3% 18:00 
18:15   END of 3% CO2  18:15 
18:30 PANAS/GHQ-28/ 
Headache 
SCOT survey 
Urine 6, BW 
Tilt Table + 
Echocardiography 
18:30 
18:45 spirometry/CO/ETCO2 
Phono / BGA 
18:45 
19:00 Dinner 19:00 
19:15   19:15 
19:30 LOG PANAS/GHQ-28/ 
Headache 
SCOT survey 
Urine 6, BW 19:30 
19:45 Departure DLR spirometry/CO/ETCO2 Phono / BGA 
19:45 
20:00 Dinner 20:00 
20:15     20:15 
20:30   LOG PANAS/GHQ-28/ 
Headache 
SCOT survey 
20:30 
20:45   Departure DLR 20:45 
21:00   Dinner 21:00 
21:15     21:15 
21:30     LOG 21:30 
21:45     Departure DLR 21:45 
22:00     22:00 
22:15       22:15 
22:30       22:30 
22:45       22:45 
 
Temp = body temperature, BP = blood pressure, HR = heart rate, BW = body weight, BD = blood 
draw, CO-Hb = plasma volume via carbon monoxide rebreathing technique, fam = familiarization 
session, Puffy face = forehead tissue ultrasound, NIRS = Near-infrared spectroscopy, TCD = 
transcranial Doppler ultrasound, Cflow = cortical microvasculature cerebral blood flow 
measurement, Fino = finometer cardiovascular parameters measurement, BGA = blood gas analysis, 
IOP = intraocular pressure, OCT = optical coherence tomography, Vittamed = non-invasive ICP 
measurement, Sniffin’ Sticks = olfactory threshold test, Spiro = spirometry derived respiratory 
parameters measurement, ETCO2 = end tidal CO2, Phono = phonocardiography, Cerebrotech = 
volumetric integral phase-shift spectroscopy measurement, MRI = magnetic resonance imaging, 
PANAS = positive and negative affect schedule questionnaire, GHQ = general health questionnaire, 
LOG = subject anecdotal daily incidence log, FMD = brachial artery flow mediated dilation 
measurement, SCOT survey = end of study survey. 
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Document A 1: Ethical approval letter from the Ärztekammer Nordrhein for the enVIIP study 
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Document A 2: Ethical approval letter from the Ärztekammer Nordrhein for the SpaceCOT study 
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Document A 3: Ethical approval letter from the Ärztekammer Nordrhein for the SETI study 
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Document A 4: SpaceCOT study co-investigators list 
 
Institute of Aerospace Medicine, German Aerospace Center [Cologne, Germany] 
Karina Marshall-Bowman, MS 
Jörn Rittweger, MD 
Edwin Mulder, PhD 
Ulrich Limper, MD 
Petra Frings-Meuthen, PhD 
Darius Gerlach, MS 
Claudia Stern, MD 
Bernd Johannes, PhD  
 
Department of Neurology, University of Cologne [Cologne, Germany] 
Henning Stetefeld, PhD, MD 
Christian Dohmen, PhD, MD 
 
Space Medicine Office, European Space Agency [Cologne, Germany] 
Tobias Weber, PhD 
Center for Space Medicine, Baylor College of Medicine [Houston, TX, USA] 
Eric M. Bershad, MD 
Jose I. Suarez, MD 
Chethan P. Venkatasubba Rao, MD 
Jonathan Clark, MD, MPH 
Dorit Donoviel, PhD 
Haleh Sangi, PhD 
Rahul Damani, MD 
 
Harvard Medical School [Boston, MA, USA] 
Gary Strangman, PhD 
 
Department of Psychiatry, University of Pennsylvania [Philadelphia, PA, USA] 
 Mathias Basner, MD, PhD 
 
University of Texas – Houston [Houston, TX, USA] 
Larry Kramer, MD  
Khader Hasan, PhD 
 
The SpaceCOT study was supported by the National Space Biomedical Research Institute 
(NSBRI) through NASA NCC 9-58, Baylor College of Medicine Center for Space Medicine and 
the German Aerospace Center (DLR) Institute of Aerospace Medicine.  
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